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INTRODUCTION 
The Department of Obstetrics and Gyne­
cology welcomed the opportunity to present the 
51 st Annual McGuire Lecture Series. The lec­
tures were designed to provide the primary care 
physician with information which is clinically 
useful and applicable to the daily practice of ob­
stetrics and gynecology. An effort was made to 
achieve a balance between those health prob­
lems that have been known for some time but 
whose understanding has changed and those 
problems that have been recognized more re­
cently and whose solutions are still evolving. 
Dr. David H. Nichols, at present Professor 
and Chairman, Department of Obstetrics and 
Gynecology, Brown University School of Medi­
cine, was the 51 st McGuire Lecturer. He is welj 
known for his knowledge of the gynecologic lit­
erature, his research into the problem of pelvia 
relaxation, and his surgical expertise. Dr. Niche 
ols has published numerous articles on femalei 
pelvic anatomy, pelvic relaxation and vaginal 
surgery In addition he has co-authored texts on 
gynecologic pathology and vaginal surgery. 
W. GLENN HURT, M.D., Professor< 
Department of Obstetrics and 
Gynecology 
Antenatal Genetic Studies 
FAY REDWINE. MS, MD 
Department of Obstetrics and Gynecology, Department of Human Genetics, and Clinical Director, 
Antenatal Genetic Testing Program, Medical College of Virginia. Health Sciences Division of Virginia 
Commonwealth University, Richmond, Virginia 
The Antenatal Genetic Testing Program at 
MCV began in 1973. The standard scheme for 
antenatal genetic testing involves counseling. 
the methods of carrier detection available, ul­
trasound, amniocentesis, and laboratory evalu­
ation. Patients are referred because of a family 
or personal history of a genetic abnormality or 
because they have been evaluated in a carrier 
detection program like those for Tay-Sachs dis­
ease or Sickle Cell disease and are known car­
riers. After referral, patients are given genetic 
counseling by me and members of the Depart­
ment of Human Genetics; if antenatal genetic 
testing is deemed appropriate, we obtain in­
formed consent and proceed with an ultrasound 
study. The primary reason for doing an ul­
trasound study prior to amniocentesis is to de­
tect twins. Twins are most likely to be in sepa­
rate amniotic sacs and have different 
karyotypes; therefore, fluid must be obtained 
from each sac. 
The indications for referral are listed in 
Table 1. The most frequent is advanced mater­
nal age, generally considered to be 35 years or 
greater. If a mother is less than 35 years and 
pregnant, she has a 0.2% risk of having a child 
with Down Syndrome (about 1 in 600). Between 
35 and 40 years of age the risk of having a 
child with Down Syndrome is between 1 % and 
1 %% and between 40 and 45 years of age it is 
about 2% or about a 5 to 1 0 times greater risk 
than the general population. 
Another common reason for ultrasound 
Correspondence and reprint requests to Dr. Fay Red­
wine. Box 34, Medical College of Virginia, Richmond VA 
23298. 
study is that the patient has had a previously 
chromosomany abnormal child. The most com­
mon abnormality is Trisomy 21 in which case 
risk of the recurrence is 1 %. Occasionally, we 
find that the proband has a translocation abnor­
mality and that one of the parents is a balanced 
carrier which results in a rate of recurrence of 
from 20% to 1 00%. A significant family history 
of chromosomally abnormal offspring (sister, 
brother. and their children) may also be a clue 
lo a translocation defect. Other indications for 
studies include metabolic defects amenable to 
prenatal detection and a previous child or 
known carrier status for a sex-linked disease 
(hemophilia or Duchenne muscular dystrophy). 
The history of a previous child or close relative 
with a neural tube defect (NTD) (either anence­
phaly, encephalocele or meningomyelocele) is 
a very common reason for referral_ Neural tube 
defects have a genetic component, so that if a 
couple has had an affected child, the risk of a 
subsequent child with a NTD is 5%, and if there 
have been two affected children, the risk is 
10% for having a child with a NTD. Patients 
with close relatives with a NTD have a 1 % risk 
of occurrence. 
As mentioned, ultrasound is used primar­
ily to diagnose twins. Once twins have been 
ruled out ultrasound is very useful for locating a 
pocket of amniotic fluid and measuring the 
angle and depth at which the needle has to en­
ter the sac to withdraw fluid. The Figure is an ul­
trasound visualization of a uterus, with the fetus 
inside, at about 14 weeks gestation. The chest 
and head are easily identified, as is a thick ante­
rior placenta. The amniotic fluid is the dark area 
and the proper needle placement is indicated. 
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TABLE 1 
Indications for Referral for Antenatal Genetic Testing 
I Advanced malernal age (2: 35 years old) 
2 Previous child with a chromosome abnormality 
3 Parents who carry a transtocation gene 
4 Previous child with an inborn error of metabolism 
5 Previous child with a severe X-1,nked disease 
6 Previous child or close retat,ve w,th a neural tube defect 
Amniocentesis is the procedure by which 
amniotic fluid is obtained through the abdomen 
of the mother with a needle. (If we have prob­
lems obtaining fluid we can use ultrasound in 
con1unction with amniocentesis to see the tip of 
the needle ) We use a disposable kit for amnio­
centesis which has a 22-gauge spinal needle, 
local anesthesia, and Betadine swabs, which 
are used to prepare the abdomen after we have 
decided where the needle is to be inserted. Af­
ter draping the abdomen with a sterile towel, the 
skin and subcutaneous tissue is anesthetized 
and the needle is inserted. The needle has a 
stylet which is then removed and an extension 
tube attached without interrupting the flow of 
fluid being withdrawn through the needle. Since 
the most common laboratory evaluation from 
the amniotic fluid is chromosome analysis, the 
fluid is processed by the cytogenetic lab in the 
Department of Human Genetics. It takes three 
to four weeks to complete the analysis with a 
range of about two and one half to six weeks. 
The fetal karyotypes are obtained from cultured 
fetal cells in the amniotic fluid obtained at 1 4 to 
1 6 weeks gestation 
Another fairly recent and exciting area in 
the field of intrauterine diagnosis is that of fetal 
structural defects. The first group successfully 
diagnosed is Neural Tube Defects (NTD) with 
the association of elevated amniotic fluid alpha­
fetoprotein in pregnancies with a NTD. In 1972 
Brock and Sutcliff' published a series of pa: 
TABLE 2 
Results of Antenatal Genetic Testing 
9-1-73 to 9-6-79 
269 46XY (normal mate) 
255 46XX (normal female) 
5 46XX+21 and 46XY+21 (Trisomy 21) 
45XO (Turner syndrome) 
4 ?XX+ 18 (Trisomy 18) 
4 5XY. I ( 1 8p 21 p) 
46XX 46XXr(9) (mosaic) 
45XX, I( 14q,21 q) 
46XX. 45 XO (mosaic) 
46XX. I (6p, l 4p) 
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tients in whom they had measured the amnioti� 
fluid alpha-fetoprotein and found that there was 
clearly a significant difference between a group 
affected with NTD and a normal control group. 
The most accurate range of pregnancy to mea­
sure alpha-fetoprotein is 1 4 to 1 8 weeks. The 
diagnosis of anencephaly and large men­
ingomyeloceles can also be made easily with 
modern ultrasound techniques. Because men­
ingomyeloceles and spina bifida are more diffi­
cult to demonstrate by ultrasound, we rely 
mainly on alpha-fetoprotein in the amniotic fluid 
for their detection. In addition, with more so­
phisticated ultrasound equipment, we are able 
to diagnose other structural defects such as 
dwarfism (by measuring fetal limb lengths) and 
polycystic kidneys (Potter syndrome). 
A number of questions are frequently 
asked about this testing Could you accidentally 
hit the baby with the needle? This has certainly 
happened and has been reported in the litera­
ture. I reviewed one series with an intracardiac 
fetal puncture and death during an amniocen­
tesis at 1 6 weeks. The recorded pregnancy loss 
rate nationwide is about 1 % as a result of am­
niocentesis. At MCV two pregnancies have 
been lost in a series of 531 patients One pa­
tient developed chorioamnionitis within 24 
hours and one patient had ruptured membranes 
about an hour after the procedure, giving a fetal 
mortality of 0.4%. We have had no fetal punc-
F,gure- Ultrasound visualization of a fetus in utero at 1 4 
weeks gestation 
tures. This 1s an acceptable mortality rate con­
sillering that most of these patients have at least 
a i1 % risk of having an abnormality and some 
as high as 5%. 
Another common question is, how much 
does it cost to have the testing?2 The cost var­
ies from center to center, but the range in Vir­
ginia is $4 70 to $520. MCV charges $520 
which includes genetic counseling, amniocen­
tesis, ultrasound study and karyotype examina­
tion. If the patient needs only the alpha-fetopro­
tein determination, the cost is $1 7 5. The MCV 
experience with antenatal genetic studies in­
volves 531 patients, the majority of whom were 
studied because of advanced maternal age. 
The second most common indication was a pre-
v1ous cl11ld with a NTD and the third was a pre­
vious child with Trisomy 21 The rest were a va­
riety of indications; perhaps the most interesting 
was one patient who demanded elective sex de­
termination. The results of chromosome analy­
sis from our patients are presented in Table 2. 
Five fetuses were diagnosed as having Down 
Syndrome, and of seven fetuses with abnormal 
alpha-fetoprotein, all had a NTD. All abnormal 
fetuses were aborted and the diagnosis con­
firmed. 
REFERENCE 
1 BROCK OJH. SuTCUFF RG: Alpha-fetoprotein ,n the ante­
natal diagnosis of anencephaly and sp,na bifida. Lance! 
2197-199, 1972. 
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Identification of the High-Risk Gravida 
ROBERT E. PETRES, MD 
EMILY M. COOGAN, RN, MS, OGNP 
Department of Obstetrics and Gynecology, Medical College of Virginia, Health Sciences Division of 
Virginia Commonwealth University, Richmond, Virginia 
In the past, there has been considerable 
pessimism about our ability to identify the preg­
nant patient at risk. However, with the develop­
ment of sophisticated diagnostic techniques 
these patients can be identified and with appro­
priate treatment their outcome can be im­
proved. This paper presents the overall benefit 
of categorizing obstetrical patients, the method 
that has been developed at the Medical College 
of Virginia (MCV), and certain categories of 
high-risk obstetrical patients who continue to 
present problems and have unacceptably high 
complication rates. 
A variety of systems has recently ap­
peared in the literature designed to categorize 
the high-risk obstetrical patient' To be success­
ful such a system must be accurate and simple 
enough to understand. Some of the initial sys­
tems of categorization were simply too com­
plicated They involved the tabulation of mul­
tiple factors drawn from virtually every aspect of 
the patient's lifestyle, physical examination, and 
laboratory assessment Consequently, they 
were too cumbersome to be practical The goal 
of any identification system should be to sepa­
rate patients into groups which can then be 
managed according to the common require­
ments of each group. 
The classification system used at MCV is 
based on the premise that a given pregnancy 
may represent a progressive risk to the fetus or 
the mother and that this risk can be attenuated 
by appropriate care. Not included in the system 
Correspondence and rep11nts requests to Dr. Robert 
E. Pel<es. Box 34. Medical College of Virg,n,a. Richmond. 
VA 23298 
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are patients at risk for congenital anomalies. 
This group of patients undergoes comprehen­
sive early antenatal evaluation. The results of 
this evaluation are then made available to the 
parents. who in turn determine what action is to 
be taken. On the other hand, there is a larger 
group of patients whose pregnancies are at pro­
gressive risk in utero. Identification, classifica­
tion and appropriate intervention can improve 
perinatal outcome in this larger group. 
The MCV identification system is divided 
into four categories. It was recognized at the 
outset that obstetrical patients could not simply 
be separated into normal patients and high-risk 
patients If this were done, 90% of the patients 
would be in the high-risk category and only 
1 0% in the normal category Instead, it seemed 
more logical to group patients according to the 
severity of their problems. 
Class IV Critical care pregnancies 
Eclampsia 
Severe preeclampsia 
Chronic hypertension with superim­
posed preeclampsia 
Chronic renal disease uncompensated 
(creatinine 1 .2 mg/% or greater) 
Organic heart disease uncompensated 
(early signs of failure) 
Hemoglobinopathies in crisis 
Pyelonephritis, acute 
Premature rupture of the membranes 
Premature dilatation of the cervix in the 
second half of pregnancy 
Diabetes (ketonuria) 
Placental accidents (abruptio placenta 
and placenta previa in the second 
half of pregnancy) 
Class Ill High-risk pregnancy 
Mild preeclampsia 
Diabetes without evidence of ketonuria 
Chronic hypertension 
Chronic renal disease compensated 
(creatinine less than 1 .2 mg/%) 
Organic heart disease compensated 
(no signs of failure) 
Hemoglobinopathy, disease stable 
(hemoglobin less than 1 0 gm%) 
Rhesus negative, sensitized 
Previous intrauterine fetal demise in 
second half of pregnancy 
Proven intrauterine growth retardation 
Maternal weight loss 
Gestational age documented greater 
than 4 2 weeks 
Multiple pregnancy 
Maternal weight greater than 300 
pounds 
Deficiency anemias (hemoglobin less 
than 1 0 gm/%) 
Class II At-risk pregnancy 
Maternal weight between 250 and 300 
pounds 
Hemoglobinopathy, trait (hemoglobin 
10 gm/% or greater) 
Deficiency anemias (hemoglobin 1 0 
gm/% or greater) 
History of urinary tract infections 
Bacteriuria 
Rhesus negative, unsensitized 
Suspected intrauterine growth retarda-
tion 
Inadequate maternal weight gain 
Previous cesarean section 
Previous premature baby 
Previous baby 1 0 pounds or greater 
Class I Normal pregnant patients 
Critical care pregnancies (Class IV) are 
those pregnancies in which there is an imminent 
possibility of decompensation. As is apparent 
from the diagnoses, there is a risk of death to 
the fetus or the mother. These patients should 
generally be cared for in the hospital. 
High-risk pregnancies (Class Ill) include 
those that are not quite as critical as the Class 
IV type but whose diagnoses carry an unaccep­
tably high perinatal loss. This is the category at 
which all the "new" antepartum testing tech-
niques and methods of management have been 
directed. Specialized high-risk obstetrical clinics 
have been developed in referral centers to eval­
uate and closely follow patients in this category. 
The most substantial improvement in perinatal 
outcome can be realized in the Class Ill cate­
gory. 
At-risk pregnancies (Class II) need to be 
identified but do not require specialized surveil­
lance. From the nature of the diagnoses it is ap­
parent that all these patients have the capacity 
to decompensate and therefore require close 
supervision. 
Low-risk pregnancies (Class I) include pa­
tients with normal pregnancies Frequently, the 
least number of patients are found in this cate­
gory. These are patients with normal histories, 
normal physical examinations and normal labo­
ratory values. Their pregnancies follow the pro­
jected course for fundal growth, maternal 
weight gain, blood pressure, and all other pa­
rameters of normal pregnancy. 
It is important to note that the assignment 
of a classification does not mean that the pa­
tient is necessarily going to remain in that classi­
fication throughout the pregnancy. Patients may 
shift from one class to another as their status 
improves or worsens. For example, if a patient 
has an iron deficiency anemia with hemoglobin 
of 11 gm/% she is placed in the Class II cate­
gory. She is counseled about nutrition and ap­
propriate diet, and iron supplements are pre­
scribed. If, however, her hemoglobin drops to 9 
gm/% as her pregnancy progresses, she is 
then placed in the Class Ill category. This may 
mean that she is transferred from a routine ob­
stetrical clinic to a high risk clinic with special­
ized surveillance. 
There are several diagnoses contained in 
the classification system that are of special in­
terest. One such diagnosis is maternal weight 
loss (Class Ill). 
In the past, not enough attention has been 
paid to adequate weight gain in pregnancy. A 
great deal of emphasis has been placed on ex­
cessive weight gain yet poor weight gain or 
worse, weight loss, has not been so readily rec­
ognized. It is important to realize that the corre­
lation between low-birth-weight infants and lack 
of maternal weight gain is greater than with any 
other single factor. When charts are examined 
retrospectively for factors such as parity, so­
cioeconomic status, maternal weight gain, lox-
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emia, renal disease. cigarette smoking, and 
number of children, the greatest influence on 
fetal weight gain is maternal weight gain. 
Poor fetal weight gain is not necessarily 
due to the fact that the mother's nutritional 
status is inadequate. Maternal weight gain is 
predicted both on her nutritional status and on 
the size of her fetus. If there is a problem pre­
venting the growth of the fetus, such as rubella, 
the mother will not gain weight. This mother can 
be fed an adequate diet. but the baby will not 
grow because of its limited potential. Decreased 
maternal weight may cause poor fetal growth, 
but the reverse is also true. Poor fetal growth 
may be responsible for limited maternal weight 
gain. 
Suspected intrauterine growth retardation 
(IUGR) is another category that deserves special 
attention because of the difficulty of diagnosis. 
Suspected intrauterine growth retardation, as 
measured by biparietal diameter with ul­
trasound, is often an iatrogenic problem Er­
roneous measurements. or studies done too fre­
quently, may indicate that there is lack of 
growth in the biparietal diameter. This points to 
the possibility of placental or fetal compromise. 
although, in fact. it may be nothing more than 
laboratory error. 
Intrauterine growth retardation diagnosed 
prior to 28 weeks gestation should be extremely 
suspect. Even in placental insufficiency syn­
dromes. the fetal head usually continues to 
grow past 28 weeks, and it is extremely unlikely 
that the diagnosis of IUGR can be made from 
biparietal diameter data before that time. A 
biparietal diameter four or more weeks behind 
the dates prior to 28 weeks usually indicates 
"wrong dates." 
Hypertensive disorders in pregnancy are 
important because of their frequency and be­
cause of the profound effects they have both on 
the mother and the fetus. They are divided into 
the toxemias (eclampsia and preeclampsia). 
chronic hypertension, gestational hypertension, 
and toxemia superimposed on hypertension. 
Gestational hypertension is hypertension that is 
unmasked in pregnancy but without the criteria 
for the diagnosis of toxemia. 
Making the appropriate diagnosis of hy­
pertensive disorders in pregnancy can be con­
fusing. However, high blood pressure, regard­
less of etiology, has a deleterious effect on the 
end organs, be it the brain. the liver, the kidney, 
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the cardiovascular system or the placenta. 
While it is important to establish a diagnosis, it ist 
more important to realize that the magnitude o� 
the blood pressure and the extent of end organ 
damage is directly proportional to fetal-maternal 
morbidity and mortality. In a series of hyperten" 
sives with proteinuria, the perinatal mortality, 
rate was 3 7. 9 per 1 000 births. This compared 
with a rate of 17.2 per 1000 for normotensive 
patients without proteinuria. 2 In patients with· 
diastolic blood pressure greater than 120, the 
perinatal mortality is 50%. 3 
Hypertensive syndromes in pregnancy, 
continue to result in maternal mortality The out­
come is compromised particularly if accelerated: 
hypertension occurs in the third trimester. Gen­
erally this is categorized as chronic hyper­
tension with superimposed toxemia.' Chesley 
reports that hypertension is rarely aggravated in 
pregnancy unless there is significant cardiac, 
renal, or retinal pathology.• What must be em­
phasized. however, is that this type of pathol­
ogy is fairly common in hypertensives and when 
these women become pregnant they are at in­
creased risk. 
In the past several years much attention 
has been directed at predicting the patient who 
will develop hypertension in pregnancy. Dalton 
looked at weight gain as an indicator.6 She re­
ported the incidence of preeclampsia to be 
26% in patients who gained more than 1 % 
pounds per week after the 30th week of gesta­
tion. The weight gain she is alluding to is not 
really caloric weight gain but rather fluid reten­
tion which is one of the triad of symptoms asso­
ciated with preeclampsia Edema. however. 
does not correlate well with increased perinatal 
morbidity and mortality. In fact, fluid retention is 
the least significant of the triad of hypertension, 
proteinuria and edema in relationship to peri­
natal mortality. 3 Chesley has demonstrated that 
the diastolic blood pressure is the most signifi­
cant factor in patients who will develop hyper­
tension in pregnancy. 5 In his study, diastolic ele­
vation occurred as the first symptom in 58% of 
patients whereas proteinuria occurred as the 
first symptom in only 34%. Proteinuria is only a 
reflection of the end organ damage to the kid­
ney in hypertensives. In toxemia the vascular 
changes resulting in decreased perfusion of vi­
tal organs is frequently long standing prior to a 
noticeable elevation in the diastolic blood pres­
sure. Indeed, Gant and others' have demon-
strated that the vascular changes typical of tox­
emia occur as early as 24 weeks. Using 140/ 
90 as a standard, the physician may not be 
able to appreciate an elevation until 35 or 36 
weeks when end organ damage is already sub­
stantial. If the diastolic blood pressure is 75-85 
mm Hg, the perinatal mortality is about 7 per 
1000. As the diastolic pressure increases to 
85-90 mm Hg the rate is 10 per 1000. When 
the diastolic is 90-104 mm Hg, the perinatal 
mortality triples what it was at 7 5 mm Hg and 
there is a progressive linear increase in perinatal 
mortality as the diastolic blood pressure contin­
ues to elevate.' A diastolic reading of 90 mm 
Hg at any point in pregnancy is distinctly abnor­
mal. 
Calculation of the mean arterial pressure 
(MAP) is the most sensitive method of predicting 
impending hypertension in pregnancy. This 
measurement is obtained using the following 
formula. 
MAP = S
ystolic + 2 Diastolic 
3 
A MAP greater than 90 in the second trimester 
or greater than 105 in the third trimester is 
prognostic of hypertension, either gestational 
hypertension or toxemia.• 
Page and Christianson calculated MAP in 
the second and third trimesters and correlated it 
with outcome.• They found that when the MAP 
went from 90 to 95 or greater, the incidence of 
preeclampsia tripled. It is important to note that 
a blood pressure of 140/90 yields a MAP of 
well over 1 00. A blood pressure reading that 
may appear grossly normal is often abnormal 
when calculating its mean arterial pressure. 
Diabetes in pregnancy, while it represents 
a much smaller proportion of patients than the 
hypertensives, continues to be a problem. Dia­
betic pregnancies carry a perinatal death rate 
four to five times higher than normal preg­
nancies.• The outcome depends largely on the 
severity of the diabetes and the amount of vas­
cular disease present prior to pregnancy. Some 
of the common problems seen in these preg­
nancies are congenital anomalies (6%), oligohy­
dramnios, premature rupture of membranes, 
macrosomia, toxemia (13% to 50%), urinary 
tract infections, increased incidence of cesa­
rean section, birth trauma and intrauterine 
deaths. In addition, babies of diabetic mothers 
experience many problems in the newborn nur-
sery. They include hypoglycemia, respiratory 
distress syndrome, and hyperbilirubinemia. 
The key to improved outcome in diabetic 
pregnancies centers around early diagnosis and 
strict metabolic control. Patients with a family 
history of diabetes or macrosomic babies, 
(greater than 4000 grams) should have a glu­
cose tolerance test to screen for diabetes. In 
women who have had a previous baby weighing 
more than 4000 grams, 10% have undiag­
nosed diabetes. ' 0 These women have high 
blood sugars which stimulate the fetal pancreas 
to produce insulin. Insulin acts like growth hor­
mones in the fetus resulting in macrosomia. 
Glycosuria in pregnancy is another indicator to 
screen for diabetes. It cannot be dismissed as a 
decreased renal threshold for glucose or as ga­
lactosuria secondary to breast development. 
Any patient with glycosuria in pregnancy should 
be considered diabetic until proven otherwise. 
Finally, patients with a poor obstetrical his­
tory should be screened for diabetes. This in­
cludes previous congenital anomalies, stillbirth, 
and repeated pregnancy loss. 
In conclusion, the classification system 
developed at the Medical College of Virginia to 
identify the high-risk gravida has been pre­
sented with a discussion of some of the prob­
lems in pregnancy that carry a high perinatal 
mortality. The importance of classifying patients 
according to risk is emphasized so that appro­
priate management can ensue. In this way, 
pregnancy outcome can be improved. 
REFERENCES 
1. AUBRY RH, PENNINGTON JC: Identification and evalua­
tion of high risk pregnancy: The perinatal concept. Clin 
Obstetr Gyn 16:3-27, 1973. 
2. NAEYE RL, FRIEDMAN EA: Causes of perinatal death as­
sociated with gestational hypertension and proteinuria. 
Am J Obstetr Gyn 133:8-10, 1979. 
3. FRIEDMAN EA, NEFF RK: Hypertension-hypotension in 
pregnancy. JAMA 239:2249-2251, 1978. 
4. CURET LB, OLSON RW: Evaluation of a program of bed­
rest in the treatment of chronic hypertension in preg­
nancy. Obstef Gyn 53:336-340, 1979. 
5. CHESLEY LC: Hypertensive Disorders in Pregnancy. 
New York, Appleton-Century-Crofts, 1978, p 4 78. 
6. DALTON K: Early symptoms of preeclamtic toxemia. 
lancef 1: 198-199, 1960. 
PETRES AND COOGAN: HIGH-RISK GRAVIDA / 7 
7. GANT NF, CHAND S, WORLEY RJ, EL AL: A clinical test 
useful for predicting the development of acute hyper­
tension in pregnancy. Am J Obstet Gyn 120:1-7, 
1974. 
8. PAGE EW, CHRISTIANSON R: The impact of mean arterial 
pressure in the middle trimester upon the outcome of 
pregnancy. Am J Obstet Gyn 125:740-746, 1976. 
8 / PETRES ANO COOGAN: HIGH-RISK GRAVIOA 
9. Report of the Workshop on Pregnancy. National Com: 
mission on Diabetes, 3(2): 179, 1976. 
10. GYVES MT. RODMAN HM, LITTLE AB, ET AL: A moderr 
approach to management of pregnant diabetics: J 
two-year analysis of perinatal outcomes. Am J Obste� 
Gyn 128 606-612, 1977. 
Management of the High-Risk Gravida 
SHELBY JARRELL, M.D. 
Assistant Professor, Department of Obstetrics and Gynecology, Medical College of Virginia, Health 
Sciences Division of Virginia Commonwealth University, Richmond, Virginia 
Comprehensive prenatal care has be­
come the hallmark of modern obstetrical prac­
tice. Awareness by both physicians and pa­
tients that such care is necessary for 
satisfactory perinatal outcome has led to the es­
tablishment of an obstetrical subspecialty, Ma­
ternal Fetal Medicine, to provide a higher level 
of prenatal care and to increase our knowledge 
of perinatal events. Many of the management 
techniques currently being used for high-risk 
pregnancies can be readily applied to the rou­
tine obstetrical population. The additional physi­
cian time and laboratory tests required are mini­
mal, and the early identification and prevention 
of perinatal complications will eliminate the 
need for "crisis" medicine. 
Identification of the High-Risk Patient 
The first step toward initiating a manage­
ment plan for a high-risk pregnancy is recogni­
tion that a poor perinatal outcome is possible. 
Early identification of the "at-risk" fetus begins 
with the first antenatal screening visit. Although 
most conditions associated with an adverse ma­
ternal or fetal outcome have long been recog­
nized, I have found it helpful to use a risk-scor­
ing approach that provides a semiquantitative 
risk estimate. 1· 2 This method takes into consid­
eration various historical, physical, and labora­
tory data to generate a numerical risk score; in 
general, as the risk score increases, the likeli­
hood of an unfavorable perinatal outcome also 
increases. Depending on the clinical setting, 
one quarter to one third of all pregnancies will 
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be identified prospectively as high risk and can 
be expected to experience the majority of peri­
natal mortality and morbidity. It is in this group 
of high-risk patients that recently developed 
methods of fetal surveillance are likely to find 
their greatest value. While details of this risk­
scoring system are beyond the scope of this 
discussion, it should be mentioned that the Vir­
ginia State Department of Health currently has 
plans to implement a risk-scoring system into 
the state health care system. 
Dr. Robert Petr es has previously ad­
dressed the problem of identification of the 
high-risk gravida. Although his classification of 
pregnancies into various risk categories based 
on the worst single antepartum complication is 
a different approach from the numerical risk­
scoring system, he accomplishes much the 
same result-prospective identification of the 
patient at risk for an adverse perinatal outcome. 
Management 
Ideally, every woman should be seen by 
an obstetrician prior to conception. At this time 
the physician may identify medical problems 
that should receive attention. The patient should 
be made aware of the importance of early pre­
natal care and be encouraged to seek an early 
diagnosis of pregnancy. The patient-physician 
relationship established at the preconception 
visit will encourage this. 
Office management of the high-risk grav­
ida begins with the initial visit. Postconception, 
patients should be seen as soon as possible in 
the office. It is difficult to convince patients of the 
importance of prenatal care if they must wait 3 
to 4 weeks for their first postconception visit. If 
the physician is not readily available, the initial 
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office screening should be performed by a 
nurse. The patient's blood pressure and urine 
should be checked, a pregnancy test performed 
to confirm pregnancy, and a check list history 
taken to identify any significant problems that 
may require immediate attention by the physi­
cian. If the patient is entirely normal with a neg­
ative history, she may be scheduled to see the 
physician at a later date; however, if a problem 
is identified on the screening visit, it should be 
dealt with as soon as possible. 
Initial Visit 
The objectives of the initial visit are to de­
termine the health of the mother and fetus, to 
determine the gestational age of the fetus, and 
to initiate a plan for continuing obstetrical care. 
A thorough physical should be performed and a 
complete history taken. Special attention should 
be given to a chronological listing of all previous 
pregnancies and include length of gestation, 
fetal weight, route of delivery, and any maternal 
or fetal complications Past obstetrical perform­
ance is the single most important historical fact 
that may predict potential problems during the 
current pregnancy The date and character of 
the last two menstrual periods should be in­
cluded at this time. Particular attention should 
be given to the funduscopic exam, thyroid, 
heart, lungs, breasts, fundal height, and to the 
presence or absence of fetal heart tones. 
Routine laboratory work which should be 
performed on all pregnant patients is listed be­
low: 
1 CBC 
2. Urine culture 
3. Urinalysis 
4 VDRL 
5. Blood type and Rh titers 
6. Atypical blood group antibodies 
7. Pap smear 
8. Gonococcal culture 
9. Rubella titers 
10. Two-hour postprandial blood sugar 
Additional laboratory work may be needed in 
selected cases depending on the patient's his­
tory and physical findings. The more common 
additional studies to evaluate patients with hy­
pertension or chronic renal disease include a 
SMA 12, SMA 6, and a 24-hour urine collection 
for protein and creatinine clearance. Diabetic 
patients will need blood sugar determinations 
and an ophthalmology consultation in addition 
1 0 / JARRELL: HIGH-RISK GRAVIDA 
to the tests for renal evaluation. Supplemental 
tests such as thyroid function tests, parathyroi<;l 
function tests, and liver function tests should be 
obtained on those patients where historical @r 
physical data suggest possible problems. The 
CBC, urine culture, and the two-hour posh 
prandial blood sugar should be repeated at 32 
weeks gestation because of the complications 
associated with undiagnosed anemia, pyelone­
phritis, and diabetes in the third trimester. In 
routine uncomplicated pregnancies no addi-· 
tional laboratory tests need be repeated. Atypi­
cal antibodies may develop in patients who be­
come sensit ized to various blood group 
antigens and many of these atypical antibodies; 
can cause erythroblastosis and intrauterine fetal: 
death. These patients need to be treated in a; 
fashion similar to an Rh negative sensitized pa­
tient. The blood bank should provide informa­
tion concerning which of the atypical antibodies 
are possible causes of erythroblastosis. Rubella 
titers should be included in all pregnant women; 
patients with positive rubella titers can be reas­
sured that rubella will not be a problem during 
the course of pregnancy Patients with negative 
rubella titers may be vaccinated in the post­
partum period If the two-hour postprandial 
blood sugar is greater than 120 mg/%, a glu­
cose tolerance test (GTT) should be performed 
to rule out gestational diabetes. Since the de­
mand for insulin increases with gestation a sec­
ond two-hour postprandial blood sugar or GTT 
should be performed at 32 weeks. 
The frequency of subsequent office visits 
must be determined according to the needs of 
the patient as should the need for additional lab­
oratory work and possible antenatal hospital­
ization. 
Regardless of the patient's high risk 
classification the objectives of prenatal manage­
ment remain the same and include evaluation of 
the maternal condition, fetal condition, and ges­
tational age These must be considered on 
each prenatal visit. Although the number of ad­
ditional visits, consultations and laboratory work 
necessary for proper evaluation should be indi­
vidualized there are certain management tech­
niques that apply to all patients in the first, sec­
ond and third trimesters of pregnancy 
First Trimester 
Maternal condition should be evaluated 
with a history and physical examination, routine 
laboratory work, and selected laboratory work 
and procedures. when indicated, to establish a 
baseline medical status during the first trimes­
ter. 
Fetal condition is difficult to assess in the 
first trimester and very little can be done to alter 
the course of pregnancy at this stage of gesta­
tion. Progressive fundal growth should be rou­
tinely documented as a means of assessing 
fetal condition. If uterine growth is abnormal or 
vaginal bleeding should ensue, ultrasonic evi­
dence of a normal or abnormal gestation sac or 
fetus will provide prognostic data; this may lead 
to earlier intervention in cases of obvious preg­
nancy loss. 
Gestational age must be accurately as­
sessed during the first and second trimesters of 
pregnancy. The difficulty in accurately assess­
ing gestational age in the third trimester is well 
known. The date, duration and character of the 
last menstrual period (LMP) should be clearly re­
corded in the chart. Additional information re­
garding the regularity of the patient's menstrual 
cycle and her most recent means of birth con­
trol should be documented. Uterine size during 
the first trimester of pregnancy is also useful in 
determining gestational age. 
Second Trimester 
Maternal condition should be evaluated 
routinely with blood pressure determination, 
maternal weight gain, and urinalysis for protein, 
glucose and acetone. The frequency of visits 
and the need for additional lab work and pos­
sible hospitalization must be determined at this 
time. The minimum interval between office visits 
for patients with otherwise uncomplicated preg­
nancies should be every four weeks. 
Although very little can be done to alter 
the course of pregnancy at this stage in gesta­
tion, fetal condition can still be evaluated by 
monitoring progressive fundal growth and the 
development of fetal movement. Should prob­
lems arise, many of the more serious fetal con­
ditions can be evaluated with a careful ul­
trasound examination. 
The second trimester of pregnancy con­
tains many gestational landmarks that are im­
portant in determining gestational age for future 
management. The appearance of the first fetal 
heart tones heard with an unamplified fetoscope 
is a reliable means of determining gestational 
age; these should be heard at 20 weeks, plus 
or minus 1 week, in the majority of pregnancies. 
From 1 7 weeks on patients should be seen 
weekly until fetal heart tones have been heard 
with the unamplified fetoscope In addition, a 
patient should also be asked to mark the date 
when she first feels fetal movement. If towards 
the end of pregnancy fetal movement has been 
present for more than 22 weeks and fetal heart 
tones have been present for 20 weeks, the pa­
tient has a 95% chance of being at least 39 to 
40 weeks pregnant. Fundal height should be re­
corded as accurately as possible in the second 
trimester of pregnancy because of the narrow 
range of standard deviation in uterine size that 
occurs at this time. The large difference in uter­
ine sizes that occurs with infants who are small, 
average or large for their gestational age does 
not usually occur until the third trimester of 
pregnancy. If fetal gestational age can not be 
reliably determined, an ultrasound study for 
.biparietal diameter should be obtained. 
Third Trimester 
The mother and fetus both require in­
creased surveillance during this period of gesta­
tion as numerous complications may arise in 
previously normal pregnancies Early recogni­
tion and proper intervention will decrease the 
perinatal morbidity and mortality associated 
with many of these developing problems 
Maternal condition should be evaluated 
every two weeks during the third trimester and 
every week during the last month. Closer obser­
vation may be required in selected patients. 
Maternal condition should be evaluated with 
routine blood pressure, urinalysis, and weight 
gain observation. Routine laboratory work 
which should be repeated early in the third tri­
mester of pregnancy includes a CBC, a two­
hour postprandial blood sugar, and a urine cul­
ture. More frequent evaluation of renal function 
tests, blood sugars and additional laboratory 
work will be necessary in selected patients. 
Evaluation of fetal condition during the 
third trimester of pregnancy has become a ma­
jor part of antepartum fetal management. Both 
biophysical and biochemical means of fetal 
monitoring are available. At the present time, 
the only useful biochemical test for evaluating 
fetal well-being is urinary or serum estriols. 
However, if estriols are to be used to predict 
fetal compromise, specimens must be collected 
daily and the results must be available to the 
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physician within 1 2 hours. An isolated or weekly 
estriol value should not be used to monitor fetal 
well-being in complicated pregnancies. 
The biophysical tests of fetal well-being in­
clude nonstressed fetal heart rate monitoring 
(NST) and an oxytocin challenge test (OCT). 3 
The decision as to when to start antenatal fetal 
heart rate monitoring should be based on the in­
dividual patient and the clinical situation. Mon­
itoring may be indicated as early as 26 to 28 
weeks of gestation in patients with advanced 
hypertension or diabetes, or delayed until 42 
weeks in a previously uncomplicated post-term 
pregnancy. In general, antepartum fetal heart 
rate monitoring should not be performed prior to 
the time in gestation when the physician would 
consider terminating a pregnancy because of 
fetal indications. There are limited data avail­
able on the use of antepartum monitoring prior 
to 30 weeks of gestation. 
Indications for antepartum fetal heart rate 
monitoring are any pregnancy at risk for uter­
oplacental insufficiency. There are no con­
traindications to the NST. The oxytocin chal­
lenge test is associated with the following 
contraindications: ruptured membranes, sus­
pected abruptio placenta, undiagnosed uterine 
bleeding, placenta previa, previous cesarean 
section, incompetent cervix, previous pre­
mature labor and polyhydramnios. In addition, 
the OCT has not been shown to be of value in 
the management of erythroblastosis fetalis. In 
general, negative OCT or reactive NST allows 
the clinician to avoid unnecessary premature in­
tervention and has a false-positive rate (fetal 
death in 1 week of monitoring) of 2 to 5 per 
1 000 A nonreactive NST or a positive OCT 
alerts the physician to possible fetal com­
promise and may be an indication for inter­
vention before fetal death or irreversible dam­
age occurs. 
The NST has been shown to be as reliable 
as the OCT. Because of the reliability and sim­
plicity of the NST, this monitoring technique has 
become the primary means of antenatal fetal 
monitoring here at the Medical College of Vir­
ginia. An outline of procedure for patient care is 
listed below. 
1. The "at-risk" patient is identified us­
ing clinical risk assessment and scor­
ing techniques at the first antenatal 
visit and as problems develop during 
gestation. 
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2 Based on the clinical situation the 
NST may be started as early as 28 
weeks. 
3 The patient is followed with weekly 
NSTs, as long as she remains reac­
tive. 
4. Any inadequate NST is repeated 
within 24 hours. Any nonreactive 
NST is evaluated the same day with 
an oxytocin challenge test. 
o If the OCT is negative, the patient is 
scheduled to have a NST the next 
week. 
6. A suspicious, hyperstimulation, or 
unsatisfactory OCT is repeated 
within 24 hours. 
7. Urinary or serum estriols may be ob­
tained for additional information, de­
pending on the clinical situation, and 
must be collected daily to be useful. 
8. If a nonreactive NST is followed by a 
positive OCT, serious consideration 
must be given to delivering the fetus. 
At this time, amniocentesis may be 
performed and if the amniotic fluid 
indicates fetal maturity, or meco­
nium-stained fluid is found, the fetus 
should be delivered. 
9. If the amniotic fluid is clear and there 
is evidence of fetal pulmonary im­
maturity, a decision is made based 
on which risk is greater, prematurity 
or the in utero environment. 
1 0 In the face of low or falling estriols, 
with a nonreactive NST and/or a 
positive OCT, we at MCV recom­
mend delivering the fetus if it is vi­
able. 
11 . If the estriols are stable and in the 
normal range, with a nonreactive 
NST or a positive OCT. the situation 
is ambiguous. A decision to await 
further maturation or to deliver the 
patient may be appropriate. Clinical 
judgment based on the overall as­
sessment of the maternal status, 
pregnancy duration. and the condi­
tion of the fetus is required. 
Determination of gestational age in the 
third trimester of pregnancy is indeed difficult. 
Ultrasound provides information about fetal size 
but does not differentiate between the small 
premature infant and the standard gestational 
age term infant. To predict gestational age re­
liably, information from the first and second tri­
mesters must be available. During the third 
trimester of pregnancy the emphasis shifts from 
gestational age to determination of fetal matu­
rity Without adequate clinical data concerning 
gestational age or when premature interruption 
of pregnancy is being considered prior to 39 
weeks, I advocate amniocentesis for a lecithin­
sphingomyelin (L/S) ratio. 
Summary 
Recognition of those patients at risk for a 
poor perinatal outcome is the most important 
step in reducing perinatal morbidity and mortal­
ity. Once at-risk patients are recognized, in­
tensive observation with frequent assessments 
of maternal condition, fetal condition, and ges­
tational age can be accomplished with minimal 
additional physician time and laboratory tests. 
The decision of when or when not to intervene 
in a pregnancy is not an easy one and should 
be based on all available data, an important 
part of which is information collected during the 
first and second trimester of pregnancy Re­
gional perinatal consultation services should be 
used more frequently for patients with manage­
ment problems. Developing problems should be 
treated aggressively with antepartum hospital­
ization, intensive observation and evaluation, 
and consultation. Proper assessment of mater­
nal condition, fetal condition, and gestational 
age will prevent many of the more serious com­
plications and may allow the patient to remain in 
her own community under the direct care of her 
local physician. If, however, the patient requires 
a level of care that cannot be provided in her 
own community, she should be transferred to a 
regional perinatal center without hesitation. 
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Relaxation of the Supporting Structures of 
the Female Pelvis 
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The purpose of this discussion is to share 
with you some thoughts about pelvic relaxation, 
its mysteries, some technical minutiae helpful in 
identifying them and some of the surgical prob­
lems involved. Thus, by looking at a number of 
these diagnostic challenges, you may be stimu­
lated to some diagnostic thinking in an office 
setting. 
Let me start with a few of the more decep­
tively simple challenges in pelvic relaxation, the 
goals we seek to achieve, and how to accom­
plish them. 
We have seen within my generation a re­
examination of sexual thinking whereby aging 
persons presume to continue a reasonably 
comfortable and satisfactory coital relationship 
well into their senior years. Solving a problem of 
procidentia or vaginal vault inversion by closing 
the vagina by LeFort colpocleisis or removing it 
by colpectomy is no longer a solution equally 
acceptable to all concerned. If we are going to 
consider a surgical approach to reconstruction 
and rebuild for someone a vagina that is both 
physiologically and sexually useful, we must 
have some idea of the purpose and benefits we 
hope to achieve by reconstruction. 
Consider, for example, the old illustration 
from Cross-sectional Anatomy by Eycleshymer 
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and Shoemaker (Fig 1). and notice that the va­
gina in this instance has an almost vertical axis. 
Is that then the goal we seek when we reposi­
tion a misplaced vagina? Or is the vagina being 
displaced anteriorly by a full rectum, which was 
full at the time of death, as this illustration obvi­
ously was from a cadaver dissection? 
To resolve the issue, the vaginas of nulli­
parous young women can be lightly painted 
with a barium paste. This would not distort the 
vagina but would render it radio-opaque. Lateral 
colpograms taken of these women demonstrate 
that the vagina does have an S-shaped curve 
with a horizontal inclination to the axis of the up­
per vagina (Fig 2) If we were to ask these nul­
liparous patients to bear down, as by a Valsalva 
maneuver, this upper axis would become even 
more horizontal (Fig 3). 
We can confirm this for ourselves daily in 
the office during vaginal examination of a nul­
liparous patient by letting the examining fingers 
follow the axis of the vagina. Usually the finger­
tips will end up in the hollow of the sacrum. 
The usual upper horizontal vaginal axis is 
clinically significant and I will now discuss how 
this axis can be destroyed or changed and 
some of the surgery that can be done to restore 
it. The vagina in this situation rests on the gen­
erally empty rectum. The only time the rectum is 
filled is in the patient with a large rectocele, or in 
someone during the act of defecation, or in 
someone recently deceased. The empty rectum 
in turn "sits" on the levator ani. The portion of 
the levator ani behind the rectum upon which it 
rests is called the levator plate It is formed from 
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Fig 1-0rawing of sagittal section through the embalmed cadaver showing the axis of the vagina to be in an almost vertical 
position. It is displaced anteriorly by the dilated rectum, a relationship not often found in the living. 
the fusion of the two halves of the pubococ­
cygeal muscle posterior to the rectum (Fig 4). 
How many different anatomic entities or 
"systems" are there concerned with keeping 
the vagina inside the body? It is really an in­
vagination, and it is unlikely that without help it 
would remain one. lnvagination has many con­
ceptual similarities to the finger of an in-turned 
rubber glove; by putting air into the glove and 
squeezing an in-turned finger promptly pops 
out. Why then does the vagina not "pop out" or 
evert more frequently than it does? Wh.at are the 
systems that affected, damaged, or missing 
parts can influence? Why is the birth canal 
where it is? 
There are actually at least six responsible 
but independent systems that influence in­
vagination. The first is the bony pelvis to which 
most of the soft tissues of the pelvis are ulti­
mately attached. If there is a defect in the bony 
pelvis, for example, a congenital defect coinci­
dent with extrophy of the bladder, the mid-por­
tion of the pubis may be missing in which case 
the rectus muscles and pubococcygeal muscles 
have a defective attachment influencing greatly 
the architecture of the anchoring supports of the 
vagina. 
Second among the six systems is the 
round and broad ligament complex; third, the 
cardinal-uterosacral ligament complex; fourth, 
the pelvic diaphragm; fifth, the urogenital dia­
phragm; and sixth, the perineum and the peri­
nea! body. Let us examine these in some detail 
to see why they influence pelvic support. 
We know, for example, that the round and 
broad ligament complex often influences pelvic 
support in a negative way. If the broad liga­
ments have been involved with either endome­
triosis or ligneous fibrosis as a result of previous 
infection, or sometimes by cancer, what would 
appear to be an easy vaginal hysterectomy isn't 
easy at all. The uterus is arrested in its descent 
by pathologic fixation from the broad ligament. 
Certainly the role of the round ligaments as at­
tributed to retro displacement of the uterus is al­
ways up for constant reexamination, particularly 
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Fig 2-A normal vaginal depth and axis. The vaginal walls of a 25-year-old, healthy nulligravida have been painted with bar­
ium. The perinea! curve of the lower vagina 1s shown along with a more horizontal axis of the upper vagina. 
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Fig 3-The same patient is straining as by a Valsalva maneuver which accentuates the horizontal axis of the upper vagina. 
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Levator plate 
Fig 4-0rawing of normal vaginal axis of the l,v,ng showing almost horizontal upper vagina and rectum lying on and parallel to 
the levator plate. 
in view of Blue Shield's national decision to ex­
clude suspension operations from those autho­
rized for payment. I do not believe that retro­
version causes uterine prolapse, but that in 
many instances the same qualities that lead to 
retroversion may also lead to the development 
of genital prolapse. These conditions may be 
separate results of common etiologic circum­
stances. The significance of this observation is 
that suspension of a retroverted uterus does not 
of itself prevent subsequent prolapse. 
We consider the cardinal ligamehts to­
gether with the uterosacral ligaments as a single 
anatomicosurgical suspensory unit: the car­
dinal-uterosacral ligament complex. 
The pelvic diaphragm consists of the leva­
tor ani and its fascia! covering, the medial por­
tion of the levator ani. The pubococcygeal mus­
cles fuse behind the rectum, constituting the 
levator plate which is so important in pelvic sup­
port. The normally horizontal axis of this plate 
will sag if the diaphram has lost its integrity. Not 
only will the hiatus or the distance between the 
anterior margin of the levator plate and the 
pubis increase, but the greater the sagging the 
greater the tendency for anything that rests on 
top of this levator plate to slide over and down, 
accentuated by the pull of gravity (Fig 5). 
The urogenital diaphragm is a sort of 
sandwich between the two pubic rami. It is pen­
etrated by the urethra and vagina, and also 
helps to support the urethra. The pubourethral 
ligamentous support of the urethra is, in fact, 
continuous with and part of the urogenital dia­
phragm, and has much clinical significance. 
Obstetrically, the posterior portion of this liga­
ment is the one most likely to be damaged. 
Pathologic stretching may cause rotational de­
scent of the bladder neck predisposing to stress 
incontinence. 
There is a big difference in the perinea! 
body between persons Defect of the perinea! 
body may be inherited, and occasionally a peri­
nea! body will be missing even in nulliparous 
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women. A defective perinea! body is sometimes 
confused with a rectocele, and if congenital in 
origin, is usually asymptomatic unless there is a 
total absence of the perineum, in which case 
the patient is said to have a so-called "double­
barrelled shotgun" type of vagina, and the vagi­
nal canal is often contaminated by rectal soiling; 
such a patient has a virtual cloaca. The urethra 
essentially lies upon the perinea! body; in in­
stances in which a urethral repair has been 
done and a perinea! defect is evident, correc­
tion of the perinea! defect is complimentary to 
the support of the urethra and anterior vaginal 
wall. 
The combinations of damage to the six 
different anatomic systems responsible for pel­
vic support that can be produced indicate why 
there is no one standard surgical procedure, for 
example, vaginal hysterectomy and repair or 
the Manchester procedure, that will solve all 
combinations of problems equally well. 
There can be permanent elongation and 
stretching of the cardinal and uterosacral liga­
ment complex permitting descent of the upper 
vagina but without any particular cystocele or 
rectocele. This may be acquired and is often 
quite significant. The process may be set in mo­
tion in someone who has had the misfortune of 
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being told to bear down during labor prior to full 
dilation of the cervix, and in so doing has 
pushed the cervix in front of the presenting part 
of the fetus. Many times that advice to bear 
down prior to full dilation has been accepted by 
the patient as a hopeful, though false and un­
knowingly dangerous means of shortening la­
bor. It has often done intractable and per­
manent damage to the supports of the vagina. 
In another situation, failure to perform an 
episiotomy in someone in whom vaginal elastic­
ity is defective may result in a cystocele and 
rectocele, even in a patient who did not bear 
down prior to full dilation of the cervix. We are in 
an era where there are some young women 
who don't want an episiotomy and who are 
questioning circumcision, as well as the need 
for hospital delivery even if operative inter­
vention of any kind in the conduct of their labor 
is indicated. We can rest assured that some can 
get by without episiotomy, but many can not 
without sustaining serious damage. How can 
one tell the difference? Probably the most im­
portant single point is separating the care of 
those who have elasticity of the vagina and peri­
neum from those who do not. 
The so-called older primapara, the patient 
over 35, generally has reduced elasticity of the 
vagina and particularly the lower portion and the 
perineum One can also distinguish the patient 
with poor elastic tissue by the presence of striae 
on the sides of the abdomen. The patient with 
many abdominal or breast striae is usually an 
obvious candidate for episiotomy if excessive 
vaginal damage is to be prevented Episiotomy 
must be performed at a proper time; not just to 
prevent a tear, but before irreparable damage 
has been done to the soft tissues. Lastly, an 
episiotomy must be properly repaired with the 
goal of reuniting structures which were tran­
sected by episiotomy, and not simply just stop­
ping the bleeding and putting the skin together. 
Anterior colporrhaphy is not so simple as 
it would appear from the three or four pages 
given in the average surgical text, so let us look 
at some of the reasons why. 
A typical conception of cystocele shows 
some pathologic stretching of the bladder that 
displaces the vagina downward. Are the symp­
toms that may be produced so predictable that 
reconstruction is always simple? The relation­
ship between the bladder, the urethra and the 
posterior surface of the pubis has much clinical 
significance with or without a coincident cys­
tocele 
Consider some of the various alterations 
that an anterior vaginal wall can undergo. Many 
years ago a characteristic descent of the 
base of the bladder during the act of voiding 
was emphasized so that the vesicourethral 
junction may be represented as a straight line. 
While this is physiologic during the act of void­
ing, it is not to a patient at rest who is not void­
ing; thus, when this flattening is apparent in 
someone who is not voiding, it indicates rota­
tional descent or "wheeling" of the vesicoureth­
ral junction with elongation of the supporting tis­
ues concerned with holding the urethra in its 
normal position. Such an altered relationship 
may be a significant factor in the production 
of stress incontinence as the vesicourethrai 
junction may now be the lowest portion of the 
hydrostatic column of water. We know that in­
continence may result from an abnormal rela­
tionship between intraurethral pressure and in­
travesical pressure as a function of urethral tone 
and not solely from positioning of the vesicou­
rethral junction. A cystocele may or may not 
coexist. The anterior vaginal wall may thus bring 
down with it the base and neck of the bladder, 
but not the bladder proper; this is not a cys­
tocele in the usual sense. Sometimes rotational 
descent of the bladder neck has been called 
"urethrocele," and one will find many refer­
ences to this fallacy in the literature, but a true 
urethrocele is a pathologic dilatation of the ure­
thra and is very rare. I think in my whole oper­
ative experience I've seen but three or four true 
urethroceles. Some of these people with a true 
urethrocele are perfectly continent. Rotational 
descent of the bladder neck is also sometimes 
called · · pseudocystocele. · · 
In addition, there may be funneling of the 
urethra. If the urethra is funneled in addition to 
the rotational descent of the bladder neck, a yet 
different set of statistics prevails, whereby the 
bottom of the hydrostatic column of urine nor­
mally located at the base of the bladder is now 
located at the base of the funnel, thus reducing 
intraurethral tone and pressure and increasing 
the susceptibility to stress urinary incontinence. 
If a patient has a cystocele serious 
enough to require anterior colporrhaphy, the op­
erator should probably repair the full length of 
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the vagina and make sure that the vesical neck 
is adequately supported and that the cystocele 
is not repaired with more tissue than required, 
thus risking the development of iatrogenic 
stress incontinence from unwitting flattening of 
the posterior urethrovesical angle. Neither 
should a cystocele be repaired with less tissue 
than required. The vagina should be precisely 
trimmed to a size suitable to the particular 
needs of the patient. 
A perinea! defect with a rectocele is a fac­
tor in the defective support of the urethra. If the 
urethra and anterior vagina rest on nothing of 
substance, any operation that has been done to 
them will tend to have less mechanical support 
than if the anterior vaginal wall rests on some­
thing of strength. Rectoceles come in various 
sizes and shapes within the pelvis; some pro­
duce symptoms and some do not. It is difficult 
to improve a patient's comfort by surgical cor­
rection of something that is asymptomatic and a 
surgeon would not normally operate on a recto­
cele or cystocele if it were producing no symp­
toms distressing to the patient and if the repair 
were not part of additional pelvic surgery. But if 
a vaginal hysterectomy were performed be­
cause of menorrhagia, prolapse, fibroid or 
something of that nature on a woman who has a 
coincident cystocele and rectocele, certainly 
the cystocele and rectocele ought to be re­
paired at the same time. 
Let us now briefly consider enterocele. It 
is sometimes described simply as a peritoneal 
hernia. Sometimes symptoms are produced, 
sometimes not. Symptoms associated with an 
enterocele are caused by gravity-induced trac­
tion upon the contents of the sac: small bowel 
or omentum. If the sac is in fact empty, the pa­
tient will be relatively asymptomatic. But the sac 
is a potential site for further distress and should 
be removed if surgery is being performed on 
other parts of the pelvis. 
Consider the difference in the relationship 
between the cul-de-sac and the vagina in the 
congenital type of enterocele versus pseudo­
enterocele. The latter may be seen in a person 
in whom a high rectocele was treated by peri­
neorrhaphy alone. Perhaps the doctor was not 
aware how high this rectocele extended be­
cause with the patient asleep and in the lith­
otomy position it is sometimes difficult to judge 
how it looks when the patient is standing. Fail-
ure to repair the full length of the rectocele gives 
rise to this condition which resembles an en­
terocele but isn't and is usually symptomatic, 
the symptom being inability to completely 
empty the bowel. The sac, which is unrepaired 
rectocele, fills with fecal material, and the pa­
tient cannot evacuate it except by digital pres­
sure in the vagina. A simple maneuver distin­
guishes enterocele from high or midvaginal 
rectocele or dropped cul-de-sac which is a 
function of support of the vault of the vagina. 
Because enterocele is most evident when the 
patient is standing, she should be examined in 
that position: index finger in the rectum, thumb 
in the apex of the fully replaced vagina and the 
patient asked to bear down. If enterocele is 
present, the physician can feel it fill with either 
small intestine or omen tum. When gently 
squeezed between the thumb and forefinger, 
discomfort is evident. In that way the physician 
can distinguish preoperatively between entero­
cele, which is a sliding hernia, and descent of 
the cul-de-sac in someone in whom the vagina 
has dropped. 
Failure to recognize and treat variances by 
appropriate surgery usually leads to post­
operative disability. 
One of the different approaches to the 
problem of massive eversion of the vagina has 
been ventral suspension or fixation of the ever­
ted vagina. Sometimes it is successful, but the 
90 degree change in the usual axis of the va­
gina imposes a risk that would otherwise not be 
present. Pulling the vagina forward without oblit­
erating the cul-de-sac has made the latter vul­
nerable to enterocele; a future enterocele that 
might not have been there had the cul-de-sac 
been obliterated. This risk is also present follow­
ing some other surgical procedures that may 
change the axis of the vagina, if no attempt has 
been made to obliterate the cul-de-sac. For ex­
ample, unless the peritoneum is opened and the 
cul-de-sac deliberately obliterated, the Marshall­
Marchetti retropubic pin-up type of operation 
will be followed by a significant incidence of 
subsequent enterocele requiring a second oper­
ation 
A transabdominal approach to eversion of 
the vagina with the aim of restoring a sexually 
useful vagina is sacropexy Affixing the vault of 
the vagina to the hollow of the sacrum has an 
advantage over ventral suspension in that the 
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normal vaginal axis is restored and the cul-de­
sac is no longer vulnerable. 
We have considered a variety of different 
kinds of damage to the supports of the pelvis. 
Let us consider the causes of damage. 
1 . Congenital defect.· not only a missing or 
underdeveloped tissue or organ but a defective 
innervation. Striated muscle deprived of an ade­
quate nerve supply may be hypotonic. 
2. Increased intra-abdominal pressure: An 
obese woman may wear a girdle that is too 
tight; maybe she is doing heavy work; or there 
is the older woman in a situation where a loved 
one, sometimes a parent, has become disabled 
by a stroke. That disabled patient must be man­
ually lifted in and out of the bed, in and out of 
the bathtub, on and off the commode, produc­
ing a massive increase in the intra-abdominal 
pressure of the person doing the lifting. Often 
there is no one else to do the lifting, but we see 
the consequences of that damage. 
3. Obstetric damage can be caused in a 
number of different ways In the 1940s we par­
ticipated in problems of home delivery, usually 
among the poor in the large cities, as part of the 
home delivery service. Delivery was conducted 
reasonably comfortably, but the consequences 
of soft tissue damage during labor were some-
times greater than would have been seen in the. 
hospital. Now there is some revival of interest in 
nonsupervised obstetric performance. Women. 
are delivering one another, and there may be a 
significant return of some of these problems of 
genital prolapse that have not been so common 
recently. Obstetric damage, even if in a hospi­
tal, is often related to the conduct of labor. We 
are considering the supports of tr,e urethra. Re­
member the damage they can sustain. There 
are at least six different combinations of dam­
age to the anterior vaginal wall. If the baby's 
head is very closely applied to the undersurface 
of the pubic arch during labor, it may damage 
these tissues in contrast to circumstances in 
which, because of either a larger fetal head or a 
narrow arch, the baby's head is pushed away 
from these tissues beneath the urethra (Fig 6). 
Two more types of damage to the vagina, and 
secondary damage to the bladder, have to do 
with the conduct of labor. In the first instance, 
the vagina has been damaged from within out. 
An "explosion" type of damage has occurred 
in which the vaginal wall has been stretched 
beyond its limits of elasticity-much like a 
piece of crepe paper that has been stretched 
and at at a certain point loses its elasticity and is 
permanently stretched out of shape. In contrast 
Fig 6--0bstetric damag_
e to the anterior vaginal wall may be greater when the baby's head has come in close contact with the 
tissues beneath the pubic arch (left). Posterior displacement of the baby's head during labor (right), is more likely to concen­
trate damage on the attachments of the posterior vaginal wall, sparing some anterior damage. 
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is a circumstance in which the labor patient has 
been told or has found herself bearing down 
prior to full dilatation of the cervix and pushes 
the cervix in front of the baby, overstretching 
the cardinal and uterosacral connective tissue 
supports of the cervix. Even when the cervix is 
fully dilated, the vagina may fail to dilate and the 
patient may push the vagina in front of the 
baby, almost like a doughnut, stretching the va­
gina itself in addition to stretching the supports, 
accounting for some of the combination dam­
age. So our old friend the cystocele is not quite 
so simple as it appears on the surface. If one 
adds the distention cystocele, the one produced 
by overstretching, and the one from dis­
placement to those six kinds of damage pre­
viously alluded to, there are now eight types. 
With displacement cystocele, the vaginal 
wall may not have been stretched out of shape, 
but it is in the wrong place. There are reason­
ably good rugal folds in each vaginal wall. This 
patient requires major attention to restoration of 
the supports of the cervix and the vagina and 
less attention to reconstruction of the anterior 
vaginal wall itself. With displacement cystocele, 
the bladder has been pulled down from its nor­
mal position by the prolapsed uterus and by its 
attachment to the cervix. 
The goal of most surgery for urinary stress 
incontinence includes elevation of the vesico­
urethral junction to a point where it is once 
again within the abdomen and, therefore, pre­
sumably responsive along with the bladder to 
changes in intra-abdominal pressure. 
The symptoms of genital prolapse are 
those of pelvic heaviness, backache, vaginal 
mass, dyspareunia and disorders of function 
primarily related to coitus or inability to empty 
the bladder or rectum. The patient may have to 
manually elevate the bladder in order to empty it 
or make digital pressure within the vagina to 
overcome inability to empty the rectum. When 
these symptoms are sufficiently disabling, or if 
they are progressive, the patient should indeed 
be treated. 
The treatment includes different kinds of 
prophylaxis. If the patient is a heavy smoker 
with emphysema, asthma, or chronic bron­
chitis, successfully getting her to stop smoking 
will lessen the insults placed on the supporting 
tissues by coughing. If the patient is too fat, she 
should lose some weight. If she's wearing a 
girdle that is too tight, she should stop wearing it 
and either lose the weight or buy a larger gar­
ment. If she is working at an occupation that re­
quires heavy lifting, for example, a dipper in a 
bumper replating factory, or someone in nursing 
who is required to lift patients and is developing 
a genital prolapse, she should try another occu­
pation. The pessary isn't used very much any­
more, although it is frequently used temporarily 
to replace the dropped tissues in someone 
awaiting surgery. Inserted and left as a definitive 
treatment, a patient will be temporarily comfort­
able enough that she may postpone surgery un­
til a time when she is much older and unable to 
respond to the stress of surgery as smoothly as 
when younger. Pubococcygeal perinea! resis­
tive excercises and voluntary contraction of the 
pubococcygeal muscles, the Kegel exercises, 
are certainly helpful in relieving many of the 
symptoms They must be done often enough: 
20 contractions in a row, three seconds each, 
six times a day, for at least three months. Ad­
vise the patient that she can do them while in 
public, as the contractions can't be seen. The 
physician can usually perceive the patient's 
pubococcygeal strength by putting one finger in 
her vagina and asking her to squeeze her va­
gina shut. One can feel whether her pub­
ococcygeal muscles are strong, and if they are 
not, estrogen replacement supplemental to sur­
gery will improve healing qualities and tissue 
strength. 
We have considered many aspects of 
genital prolapse including the clinical anatomy, 
sites of damage, causes and prevention of gen­
ital prolapse and a variety of treatments. Most 
can be readily recognized if we but take the 
time to look for them. 
Figure 1 is reproduced with permission from Carter, et 
al, Cross-Sectional Anatomy: Computed Tomography and 
Ultrasound Correlation, New York, Appleton-Century-Crofts, 
1977. 
Figures 2, 3 and 4 are reproduced with permission 
from Obstetrics and Gynecology (36:251-256, 1970). 
Figures 5 and 6 are reproduced with permission from 
Nichots, et al, Vaginal Surgery, Baltimore. Williams & Wil­
kins Company, 1 9 77. 
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Menstrual Abnormalities 
LEO J. DUNN, M.D. 
Chairman, Department of Obstetrics and Gynecology, Medical College of Virginia, Health Sciences 
Division of Virginia Commonwealth University, Richmond, Virginia 
Any physician involved in primary care will 
encounter patients with menstrual dysfunction. 
Mismanagement of this disorder is not usually 
the result of its complexity but rather the lack of 
an orderly approach. In unusual circumstances 
one may encounter a patient with a menstrual 
disorder of sufficient complexity to require refer­
ral. This decision should be based on a work-up 
indicating such a need rather than frustration af­
ter unsuccessful empiric therapeutic trials. 
The age of the patient is an important con­
sideration for evaluation; the three main cate­
gories are the adolescent, reproductive, and cli­
macteric age groups. 
Adolescent menstrual disorders are gen­
erally the concerns of ''too early,'' ''too late'· or 
"too much." Menarche, or the first period, is 
expected to occur by age 13. "Too early" 
would be prior to age 9 and "too late" would be 
after 16.5 years of age. Those who have men­
arche "too early" usually prove to be individ­
uals who have undergone the normal sequential 
events of puberty and have cyclic hypothalamic 
and ovarian function. Only one out of ten of 
these individuals will have any serious disorder 
such as brain tumor, residual damage after 
meningitis, or Albright disease. If menstruation 
has occurred but cyclic function is absent and 
ovulation does not take place, then a search for 
a source of estrogen must be made, the two 
The following is an edited transcript of remarks by Or. 
Dunn at the 51 st Annual McGuire Lecture Series, October 
19, 1979. at lhe Medical College of Virginia, Richmond, 
Virginia. 
Correspondence and reprint requests to Or. Leo J. 
Dunn, Box 34, Medical College of Virginia. Richmond, VA 
23298 
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most common sources being exogenous estro­
gen that has been ingested or endogenous es­
trogen from a theca-granulosa cell tumor of the 
ovary. 
Therefore, the first effort is to determine if 
the patient's condition reflects a full, orderly, 
pubertal change or whether it represents only 
the effect of estrogenic stimulation. If it appears 
to be true puberty, an intracranial lesion must 
then be ruled out. If it appears to be pseudo­
precocious puberty from estrogen stimulation 
with only menstrual bleeding, skeletal growth 
and breast stimulation, then a source from the 
environment or the ovaries must be sought. 
About 95% of women will have had their 
first menses by age 16.5 years and 99% by 
age 18. A detailed history and thorough phys­
ical examination will give a number of diagnos­
tic clues to a physician confronted with a patient 
who has not yet menstruated. Although it can­
not be precisely predicted, there is a relatively 
orderly sequence of events that occurs with pu­
berty. The gradual elevation of estrogens is re­
flected in the early development of the breasts, 
and about one year later, the rapid increase in 
the rate of skeletal growth. The adrenal 
changes resulting in higher levels of circulating 
androgens influence the growth of axillary and 
public hair. The onset of the first period can be 
expected within about 1 8 months of the rapid 
growth spurt. Therefore, the history and phys­
ical examination will give an indication at about 
what level the problem exists. These patients 
may present in a number of ways. 
First, let us take a 17-year-old female who 
has not menstruated and who has no secondary 
sexual characteristics. We know immediately 
that there are no significant amounts of estro-
gen being made in that individual and must de­
termine whether the gonads are at fault or if the 
disorder is central. A determination of follicle­
stimulating hormone (FSH) and luteinizing hor­
mone (LH) from plasma will divide these pa­
tients into two groups. If the gonadotropins are 
elevated, we know that we are dealing with pri­
mary gonadal failure and must obtain genetic 
studies by karyotyping. The usual abnormal kar­
yotypes found are 45X, 46 abnormal X, 46XX, 
and mosaics. If the gonadotropins are low, we 
are dealing with a central defect. The availability 
of gonadotropin-releasing hormone will allow 
the identification of those who have a hypotha­
lamic dysfunction from those with an anterior pi­
tuitary dysfunction but this hormone is not now 
generally available. At present, the method of 
management for all of these cases will be estro­
gen/ progestin substitution therapy. 
Second, we consider a 17-year-old with 
primary amenorrhea who by history had breast 
development beginning at age 11 , a growth 
spurt evident by age 1 2, and normal axillary 
and pubic hair. We would know that her gonads 
had been producing sex steroids for several 
years and that the hypothalamus and pituitary 
must be functioning. Physical examination 
would be expected to reveal some abnormality. 
An obstruction to the menstrual flow such as im­
perforate hymen might lead to a direct and 
simple solution to the problem. Absence of the 
uterus or vagina (or some combination thereof) 
requires further evaluation. At this point some 
physicians use a buccal smear, others a testos­
terone determination, in order to identify the pa­
tients with testicular feminization syndrome. If 
the findings are positive for this diagnosis, then 
gonadal removal is indicated after completion of 
pubertal changes because of the risk of malig­
nancy Gender identity for this person has al­
ways been female and this should not be dis­
rupted by informing the patient about the details 
of the condition. If a normal testosterone level or 
positive buccal smear is indicative of a genetic 
female, then surgical vaginoplasty may be nec­
essary, but gonadal removal is not necessary 
since a Y chromosome is absent. 
Third, we may be faced with a 17-year-old 
female with a nt,, mal history of puberty, normal 
secondary sexual characteristics, and both va-
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Fig. 2: Evaluation and management of menstrual abnormality during climacteric 
gina and uterus present. The evaluation of this 
individual would be the same as for the woman 
who has previously had menstrual function but 
who now has secondary amenorrhea. First, 
pregnancy should be ruled out. This may be 
done by a progestin or progesterone withdrawal 
test or by a beta human chorionic gonadotropin 
(BHCG) pregnancy test. The latter is probably 
now preferred because of the alleged terato­
genic effect of hormones when pregnancy does 
exist. Once pregnancy is ruled out, a progestin 
or progesterone withdrawal test may be per­
formed to evaluate the level of circulating estro­
gen, although the status of the endometrium 
and patency of the cervix would also influence 
the outcome. Eventually, however, in these pa­
tients a determination of FSH, LH and estradiol 
will be necessary to categorize the patient as in­
dicated in the flow sheet (Figure 1) 
The adolescent with "too much" bleed­
ing, who is otherwise normal, is most likely ex­
periencing anovulatory cycles. The diethylstil­
bestrol (DES) problem has made it important 
that visualization of the vagina and cervix be 
carried out. However, it is not necessary to 
biopsy or curette the endometrium of these indi­
viduals except under unusual circumstances. 
Management is usually by the administration of 
oral contraceptives to control the cycles, and 
oral iron to replenish its loss. 
During the reproductive age a variety of 
menstrual disorders may be found also. For 
those women whose menstrual function has 
ceased (secondary amenorrhea) we can follow 
the course of evaluation previously outlined for 
the anatomically and genetically normal adoles­
cent. For all other disturbances of the cycles, 
where bleeding is not of sufficient magnitude as 
to create an urgent problem, it is necessary to 
rule out pregnancy and to determine whether or 
not ovulation is occurring. If the patient has ex­
cessive menstrual flow or intermenstrual bleed-
ing with good evidence of ovulation (by basal 
body temperature, progesterone assay or endo­
metrial biopsy) then coagulation disorders 
should be ruled out and dilatation and curettage 
performed. If anovulation is demonstrated, en­
dometrial sampling is prudent for those women 
at the end of the reproductive scale to rule out 
abnormal hyperplasia or the rare carcinoma. In 
general, however, these patients can be treated 
by either combined oral contraceptives in a cy­
clic manner or by one week of oral progestin 
each month. When anovulation occurs it is im­
portant to recognize that there is a wide variety 
of emotional, endocrine and general health dis­
turbances that may interfere with the menstrual 
cycle Therefore, evaluation of the patient must 
be general and thorough in order that symp­
toms and signs of other disorders may be 
found. 
Menstrual change in the climacteric is ex­
pected as anovulation becomes more frequent 
and ovarian function progressively declines. 
However, some patients will experience exces­
sive bleeding and/or unpredictable frequent 
episodes of bleeding. The possibility of preg­
nancy still exists in this age group and must be 
considered. However, the most important re­
quirement for these women is the sampling of 
the endometrium. Subsequent management de­
pends upon the pathologist's findings and is 
outlined in Figure 2. 
In summary, control of menstrual function 
is a very complex system that is highly in­
tegrated and subject to a number of types of 
malfunction from both within and without. Identi­
fication of the majority of menstrual disorders is 
within the reach of physicians responsible for 
primary care but requires a thoughtful, orga­
nized approach. Inability to reach a satisfactory 
diagnosis or lack of response by the patient to 
established methods of therapy indicate the 
need for more intensive evaluation. 
Contraception Versus Sterilization 
THAMPU KUMARASAMY, MD , FRCS, FRCOG, MRCP 
Associate Professor, Department of Obstetrics and Gynecology, Medical College of Virginia, Health 
Sciences Division of Virginia Commonwealth University, Richmond, Virginia 
The World Health Organization reported 
that 40% of the pregnancies in the world in 
1977 were unplanned and 20% were un­
wanted; in the United States in 1978 there were 
1,300,000 teenage pregnancies, of which one 
million ended in abortions To prevent these un­
wanted pregnancies and also to abolish the 
cost in terms of money, time and lives, concep­
tion control is very important Contraception is 
as old as the human race. In ancient times Chi­
nese women swallowed live tadpoles three days 
atter their menses for this purpose. North Afri­
can women mixed gunpowder solution and 
loam from a camel's mouth and drank the re­
sulting potion. Egyptian women inserted pes­
saries made of crocodile dung to achieve con­
traception. Greek women in the second century 
made a vaginal plug that contained oil, honey, 
cedar gum and fig pulp; others ate the uterus of 
female mules. As recently as the 17th century, 
European brides were instructed to sit on their 
lingers while riding in coaches or to place 
roasted walnuts in their bosoms, one for every 
barren year desired. Obviously, an unwanted 
child was of as much concern to the ancients as 
it is to modern women. 
These are the characteristics of an ideal 
contraceptive: 
1 . 1 00% effective 
2. Sale with no side effects 
3. Simple to use 
The following is an edited transcript of remarks by Dr. 
Kumarasamy at the 51 st Annual McGuire Lecture Series, 
October 19, 1979. at the Medical College of Virginia, Rich­
mond, Virginia. 
Correspcndence and reprint requests to Dr. Thampu 
Kumarasamy, Box 34. Medical College of Virginia, Rich­
mond, VA 23298. 
4 Inexpensive 
5. Removed from the act of intercourse 
6. Completely reversible 
7. Easily available 
There are two types of effectiveness­
theoretical effectiveness and use effectiveness. 
Use effectiveness is invariably found to be lower 
than theoretical effectiveness. 
The varieties of contraceptive methods 
available are 
1. Chance 
2. Douching 
3. The rhythm method 
4. Use of spermicides 
5. Condoms 
6. Diaphrams 
7. Condoms and spermicides or dia­
phram and spermicides 
8. Oral contraceptives, which can be a 
combined oral contraceptive or pro­
gestin-only (minipill) 
9. Injectable contraceptives 
10. Intrauterine contraceptives 
11 . Male sterilization 
1 2. Female sterilization 
Of these, chance and douching have the 
lowest rate of effectiveness, and the rhythm 
method, or the so called "sale period," sup­
posedly one week before and one week after 
the first day of menses, should not be consid­
ered as particularly sale. 
Condoms 
Condoms have been in use since the 1 7th 
century both to prevent venereal disease and to 
avoid impregnating women. Today, in the 
United States, 700 to 800 million condoms are 
produced annually. Condoms may be a prob-
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lem for men with borderline impotence or those 
who cannot maintain an erection for some time. 
The earlier objections to the use of condoms, 
such as decrease in thermal and/or tactile sen­
sitivity have been overcome by the manufacture 
of condoms made of very thin but strong mate­
rial. In Japan, the most commonly used con­
traceptive agent is the condom. Recently, the 
International Planned Parenthood Federation 
has reported that condoms and spermicides 
used in con1unction by motivated people are as 
effective as oral contraceptives. Those con­
cerned about the use of oral contraceptives and 
their complications or the complications of intra­
uterine devices, can use condoms and spermi­
cides. And condoms have the distinct advan­
tage of preventing the spread of venereal 
disease. 
Oral Contraceptives 
The types of oral contraceptives are 1 ) the 
combination pill, 2) the progestin-only (minipill), 
and 3) the morning after pill. The mechanism of 
action of the combination pill is supposed to be 
a combination of the following: 
1 . Prevention of ovulation 
2. Some alteration of tubal transport 
3. Changes in the endometrium 
4. Alteration of the cervical mucus 
Symptoms attributed to estrogens in the 
combination pill are: 
1 . Nausea and bloating 
2. Cyclic weight gain and/or edema 
3. Nervousness, irritability and/or pre-
menstrual tension 
4. Venous or capillary engorgement 
5. Headache 
6. Breast tenderness or cystic changes 
7. Mucorrhea, cervical erosion or polypo­
sis 
8. Hypermenorrhea 
9. Dysmenorrhea 
1 0. Fibroid growth 
1 1 . Changes in carbohydrate metabolism 
1 2. Hypertension 
13. Thrombophlebitis 
1 4. Suppression of lactation 
Symptoms related to progestins are: 
1 . Amenorrhea or oligomenorrhea 
2. Acne 
3. Hirsutism 
4 Increased appetite and steady weight 
gain 
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5. Depression and changes in libido 
6. Fatigue 
7. Moniliasis 
8. Early spotting and breakthrough 
bleeding 
9. Oily scalp and loss of hair 
Side effects of oral contraceptives are: 
1 . Nausea and vomiting 
2. Weight gain 
3. Spotting and breakthrough bleeding 
4. Headache 
5. Nervousness and irritability 
6. Depression 
7. Loss of libido 
8. Breast discomfort 
9. Acne 
10. Melasma 
11 Amenorrhea 
1 2. Thromboembolic effects 
There is some concern that oral con­
traceptives may be responsible for genetic 
changes and some forms of cancer. So far: 
there is no definite evidence to support the idea 
of genetic changes, and no association, ad­
verse or beneficial, between the use of oral con­
traceptives and the development of cancer of 
the breasts, endometrium, or cervix, according 
to current data. Long-term combined oral con­
traceptive use appears to be related to the de-' 
velopment of benign liver neop\asia. There is 
also evidence that oral contraceptives may have 
an adverse influence on the resolution of hyda­
tidiform mole. 
ABSOLUTE CONTRAINOICA TIONS TO THE USE OF THE 
PILL 
Thrombophlebitis, thromboembolic 
disorders, cerebrovascular disease, or 
a past history of these conditions 
2. Markedly impaired liver function 
3. Known or suspected carcinoma of the 
breast 
4. Known or suspected estrogen-depen­
dent neoplasia 
5. Undiagnosed abdominal genital bleed-
ing 
6. Known or suspected pregnancy 
7 Congenital hyperlipidemia 
8. Gestational diabetes 
9. Progressive heart disease 
1 0 Progressive high blood pressure 
Some relative but not absolute con­
traindications are: 
1. Obesity 
2. Headache 
3. Fibroids 
The progestin-dominant pill is suitable for 
a woman if she should have: 
1 . Excessive outpouring of leukorrhea 
2. A generalized sense of bloating or 
nausea while taking a contraceptive 
with high estrogen component 
3. A tendency toward fluid retention and 
premenstrual weight gain 
4. A degree of emotional instability and 
irritability prior to the menses 
5. Excessive menstrual flow 
6. More than the average amount of fi­
brocystic disease and a tendency to­
wards swollen, tender breasts and nip­
ples 
Women experiencing the following are not 
good candidates for progestin-dominant con­
traceptives: 
1 . Hirsutism and acne 
2. Underdevelopment of breasts 
3. Very scanty menstrual flow or a fore­
shortened cycle 
4. Increasing appetite and steady weight 
gain 
5. Varying degrees of depression in the 
menstrual cycle 
6. Excess weight gain during previous 
pregnancy 
7. Intermittent depression or loss of libido 
8. Breakthrough bleeding 
THE MINIPILL 
This is a progestin-only preparation which, 
when taken as directed, is an effective oral con­
traceptive-, although it is less effective than an 
estrogen-progestin combination. The prepara­
tions available are Micronor, Nor-0.D., and Ov­
rette. The anticonception effect is due to a com­
bination of poor endocervical mucus preventing 
sperm penetration in addition to the endometrial 
changes that are out of sequence for proper im­
plantation of the blastocyst. There is also an ef­
fect on tubal motility and the enzymes in the 
endosalpinges. Presently, the majority of 
women using the minipill continue to ovulate. 
These pills are administered on a continuous 
daily basis, starting on the first day of men­
struation. The minipill seems to be perfect for 
women who cannot tolerate the combined prep-
arations because of excessive side effects such 
as nausea, weight gain and mastalgia. 
Intrauterine Contraceptive Devices 
Stoning the camel was a practice that 
dates back to ancient Egyptians who introduced 
a small oval stone into the uterine cavity of fe­
male camels to prevent them from becoming 
pregnant if they were to be used for long jour­
neys across the desert. 
Very much later, Pust, a German gynecol­
.:>gist, designed a number of cervical stem pes­
saries made of glass, a combination of metals 
and a silkworm, and used them to treat dys­
menorrhea when associated with an acutely 
antiflexed uterus. It was observed that these 
pessaries acted as contraceptives. Another 
German gynecologist, Ernst Grafenberg, elimi­
nated the part of the appliance that lay in the 
cervical canal and produced his now well­
known ring made of coiled silver wire. 
The Japanese were the first to make and 
use plastic devices, and today the following de­
vices are available for clinical use: 
1. Saf-T-Coil 
2. Lippes loop 
3. Copper-? 
4. Copper-T or Tatum-T 
5. Progestasert 
The mechanism of action of intrauterine 
contraceptive devices is not very clear. The the­
ory that increased tubal and uterine motility 
causes the fertilized egg to reach the endome­
trium before the conditions are favorable for im­
plantation has not been substa,ntiated. It is also 
believed that the inflammatory and immune re­
action within the endometrium may cause prob­
lems of implantation of the blastocyst. 
The action of copper in copper-impreg­
nated intrauterine devices is believed to be due 
to its interference with the migration of sperma­
tazoa as well as with implantation, probably by 
disrupting the sulphydryl groups in the endome­
trium and in the spermatazoa. 
HISTOLOGICAL CHANGES 
The effects of intrauterine contraceptive 
devices on the endometrium have been well 
studied in human beings. The most obvious 
changes are 1 ) an increase in the number and 
size of vascular channels, 2) a diffuse or patchy 
subsurface stromal hemorrhage, and 3) 
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changes in the amount and distribution of fluid 
in the endometrial stroma 
ADVANTAGES OF THE INTRAUTERINE DEVICE 
1 . The greatest advantage is that once 
the device is in place, no further moti­
vation, effort or treatment is required 
for continued contraception 
2. It is especially useful for those who 
have trouble following directions or re­
membering to use any other method 
3. There is a lack of systemic effects 
4. It may be most suitable for older 
women 
DISADVANTAGES OF THE INTRAUTERINE DEVICE 
1 Pain and difficulty associated with in­
sertion 
2. Side effects of cramps and bleeding 
and vasovagal reaction 
3. Failure (2% to 5% pregnancy rate) 
COMPLICATIONS OF THE INTRAUTERIN DEVICE 
1 Bleeding 
2. Pregnancy 
3. Expulsion 
4. Pain 
5. Perforation 
6. Infection 
7 Fracture of the device or loss of the 
string attached to the intrauterine de­
vice 
CONTRAINDICATIONS 
1 . Severe dysmenorrhea 
2. Menorrhagia 
3. Pelvic infection, recent or chronic 
4. Perimenopausal menstrual abnormal­
ity 
5. Congenital anomalies of the uterus 
6. Some women with fibroids 
Surgical Sterilization 
The use of sterilizing procedures is in­
creasing world wide. In the male, vasectomy is 
simple, sale and effective, but has the mild dis­
advantage of not being immediately effective. 
On the other hand, in the female, the tubal liga­
tion involves no measurable risk to life, can be 
done as an outpatient procedure, and is imme­
diately effective. Tubal sterilization in the female 
can be performed in the postpartum period or 
30 / KUMARASAMY CONTRACEPTION VS STERILIZATION 
as an interval procedure. The routes by whic� 
this procedure can be performed are via the ab­
dominal wall, via the posterior lornix of the Vi3-
gina, or by the use of a laparoscope or hys­
teroscope. Though the use of the laparoscope 
for tubal sterilization procedures has gained 
wide acceptance and popularity, the mini­
laparotomy is as safe and quick and effective iri 
selected females and has the additional advan­
tage of low cost. 
Damage to the tubes caused by coagu­
lation or cauterization via the laparoscope not 
only damages extensive areas of the tube ana 
the broad ligament, but also may cause some 
ovarian dysfunction leading to post-sterilizatiori 
problems of pain and bleeding On the other· 
hand, use of mechanical devices to occlude the 
fallopian tube such as the use of silicone rubber 
bands or plastic clips has been shown to mini­
mize the above-mentioned postoperative symp-· 
tomatology. Because the mechanical devices 
produce minimal damage to the fallopian tubes 
this method is most suitable for a young woman 
who may request tubal reanastomosis at a later 
stage. 
To date, we do not have a single revers­
ible method of sterilization. Any surgical steril­
ization method is designed to be permanent 
and tubal occlusion procedures are accepted 
as the preferred procedure for those women 
who have definitely completed their child­
bearing and who desire sterilization. Should any 
uterine pathology and/or symptomatology of 
significance be found. then hysterectomy is ac­
ceptable and fully justified as a sterilization pro­
cedure. 
Overall. from my experience. I would ad­
vise the following as the best forms of con­
traception for the various categories of women: 
Unmarried teenagers 
1. Abstinence through education and 
self-control 
2. Condoms and spermicides 
3. Diaphram and spermicides 
4. Oral contraceptives 
Married women 
1 . Condoms and spermicides 
2. Diaphrams and spermicides 
3. Oral contraceptives 
4 Intrauterine contraceptive devices 
5. Tubal occlusion by a method that 
would result in minimal damage to the 
tubes. Example: clips, bipolar cautery 
or Falope rings 
6. Hysterectomy only if uterine pathology 
of significance exists 
Women over 35 
1 _ Diaphram and spermicides or con-
doms and spermicides 
2 _ Intrauterine contraceptive devices 
3. Tubal occlusion 
4. Hysterectomy if uterine pathology or 
symptomatology of significance exists 
Preabortal women 
1 _ Suction dilatation and curettage fol­
lowed by tubal occlusion 
2. Saline abonion followed by tubal oc­
clusion 
3. Abortion-hysterectomy if, in addition, 
any uterine pathology is found 
Postabortal women who desire further fertility 
1 Barrier methods 
2 _ Oral contraception 
3 Intrauterine devices 
Postpartum women 
1 Use of condoms and spermicides 
2. Oral contraceptives 
3 _ Intrauterine devices 
4 Tubal occlusion 
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Endometriosis 
W GLENN HURT, M.D. 
RAY A. WERTHEIM, M.D. 
Department of Obstetrics and Gynecology, Medical College of Virginia, Health Sciences Division of 
Virginia Commonwealth University, Richmond, Virginia 
Endometriosis is diagnosed when tissue 
which resembles the endometrial lining exists 
outside the endometrial cavity Although first 
described as a pathological entity in the late 
1800s, the term "endometriosis" was not in­
troduced until the early 1920s by Sampson ' 
The great volume of literature which has accu­
mulated on this topic is, by and large, a product 
of the 20th century. 
Many theories exist as to the histogenesis 
of endometriosis. All may be assigned to one of 
three basic groups in which 1) endometrial tis­
sue is transplanted ectopically as a result of re­
gurgitation, metastasis, or oviduct extension, 2) 
endometrial tissue develops ectopically in situ 
from local tissues, or 3) a combination of trans­
plantation and development in situ. Of the three 
groups, only the first has been documented; the 
other two are speculative.? 
Grossly, endometriosis often presents as 
purplish, dusky red, or brownish spots or ele­
vated nodules surrounded by varying degrees 
of fibrosis and scarring Typically it involves the 
peritoneal surface of the ovary or ovaries, cul­
de-sac, or bladder. Less frequently the bowel, 
appendix, bladder, ureters, cervix, vagina, and 
vulva are involved. Rarely, it is reported in the 
umbilicus, pleura, lungs, and extremities. Trans­
plantation into surgical incisions ot the abdomi­
nal wall and perineum has been documented. 
Microscopic evidence of endometriosis is 
not always clear-cut. One would like to see en­
dometrial-like epithelium, glands or gland-like 
Correspondence and reprint requests to Or. Glenn 
Hurt, Box 34, Medical College of Virginia, Richmond, VA 
23298. 
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structures. and stroma accompanied by evi­
dence of hemorrhage. Not infrequently a picture 
"consistent with endometriosis" will present it­
self revealing hemosiderin, fibroblasts, and pig­
ment-laden macrophages However, one can­
not be secure in the pathological diagnosis if it 
is based solely on such evidence. 
Malignant degeneration occurring within 
areas of endometriosis is uncommon-less 
than 1 %. When it does occur, it is seen much 
more frequently in the glandular component as 
an adenocarcinoma than in the the stromal 
component; rarely is the malignancy of a mixed 
type Endometroid carcinoma of the ovary does 
not appear to be directly related in its histogen­
esis to endometriosis. 
Clinically, endometriosis is a disease of 
the reproductive years. Although it is being seen 
more frequently in teenagers, it has never been 
reported to occur before the menarche. The dis­
ease may pose a problem for the peri­
menopausal woman. 
The frequency with which endometriosis is 
reported to occur in a given population is highly 
variable. Perhaps as many as 20% to 25% of 
women 24-45 years old have some evidence of 
endometriosis recognizable at the time of lap­
aroscopy. It is being detected with increasing 
frequency in blacks, historically a group thought 
to have a very low incidence of the disease. 
The patient with endometriosis usually 
complains of secondary dysmenorrhea or pelvic 
pain, menstrual abnormalities, and frequently ol 
infertility 
The pain is highly variable and its severity 
often cannot be related to the extent of the dis­
ease. Pain usually begins some years after 
:nenarche and may be premenstrual or men­
strual in occurrence. Extensive endometriosis 
may be associated with chronic pain throughout 
the menstrual cycle. Sometimes the disease 
causes pelvic pressure or a sense of heaviness 
and fullness which the patient does not interpret 
as pain. Low backache and deep dyspareunia 
are usually the result of uterosacral involvement. 
Rectal and bladder tenesmus occurs and cyclic 
sciatica (Head sign) has been reported. 
Abormalities of menstruation consisting of 
hypermenorrhea and an irregular menstrual in­
terval imply ovarian involvement. Ten percent of 
patients with significant endometriosis have epi­
sodes of anovulation. As the disease is com­
monly associated with an increased incidence 
of endometrial polyps, leiomyomata, and ade­
nomyosis, these conditions must also be sus­
pect as causes of abnormal menstruation. 
Infertility may be the result of a number of 
factors: ovarian dysfunction, kinking of the ovi­
ducts, scarring of the fimbria, uterotubal spasm, 
and a decrease in coital exposure due to dyspa­
reunia and chronic pelvic discomfort. This prob­
lem becomes more perplexing, however, when 
one is reminded that most patients with endo­
metriosis ovulate, few have blocked tubal lu­
mens, and many have previously borne chil­
dren. 
The patient with complaints suggestive of 
endometriosis may or may not have the classic 
physical findings of pelvic tenderness, cul-de­
sac nodularity, organ fixation, or abnormal ad­
nexal masses. Many, with minimal endometrio­
sis, appear to offer the most complaints, 
whereas others, with extensive involvement, 
may appear relatively asymptomatic. There is 
yet another group in which endometriosis is only 
an incidental finding at the time of laparoscopy 
or laparotomy. 
Although the pelvic findings may confirm 
the suspicion of endometriosis, the diagnosis 
cannot be made unless the disease process is 
visualized or biopsied. Laparoscopy has proved 
invaluable in the diagnosis and ma�agement of 
patients suspected of having endometriosis. In­
dications for laparoscopy are given in Table 1. 
When endometriosis is encountered, diagrams 
of the extent of involvement should be entered 
in the patient's medical record. The Baylor 
classification of pelvic endometriosis is helpful 
in documenting findings and serving as a guide 
to medical and/or surgical therapy (Table 2).3 
TABLE 1 
Indications for Laparoscopy 
Severe unexplained pelvic pain 
Progressively severe dysmenorrhea 
Dyspareunia, especially with deep penetration 
Metrorrhagia uncontrolled by dilatation and curettage and/ 
or hormones 
Pelvic findings suggestive of endometriosis 
Unexplained infertility 
Medical management of endometriosis is 
aimed at the relief of pelvic discomfort and the 
preservation of the patient's childbearing poten­
tial. Initially, analgesics and heat may provide 
relief. The patient should be advised to avoid 
the continued use of narcotics and alcoholic 
beverages. It is best not to undertake the medi­
cal suppression of endometriosis using hor­
monal therapy unless the disease has been 
documented visually or by biopsy, and the ex­
tent of involvement determined. Hormonal ther­
apy is associated with many undesirable side 
effects and is expensive. Patients thought to 
have the disease but who in fact do not have it 
should be spared prolonged courses of hor­
monal therapy. 
Current hormonal regimens employ the 
TABLE 2 
Classification and Treatment 
MILD: Fresh implants. minimal scarring, no 
adhesions. minimal or no ovarian involve· 
ment 
Rx: Medical suppression­
Gestogens (pseudopregnancy) 
Danazol (pseudomenopause) 
Supportive therapy­
Analgesics. heat 
No therapy 
MODERATE: Implants with scarring and retraction, 
adhesions, endometrioma <2 cm, 
minimal peritubular and periovarian adhe­
sions 
Rx: Laparoscopic minisurgery 
Conservative surgery 
Medical suppression 
SEVERE: Endometrioma >2 cm, tube(s) and 
ovary or ovaries bound down by adhe­
sions. cul-de-sac obliteration. bowel or uri­
nary tract involvement 
Rx: Conservative surgery 
Hysterectomy with salpingo-oophorec­
tomy 
Medical suppression. postoperative. if 
indicated 
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gestogens to achieve pseudopregnancy or dan­
azol to achieve pseudomenopause Hormones 
appear to give the best results in the treatment 
of mild degrees of endometriotic involvement. 
They are capable of relieving pain and of reduc­
ing the extent of the disease to some degree; 
however. they are not likely to eliminate all foci 
of disease and thereby effect a cure. 
The gestogens, combinations of estrogen 
and progesterone, interrupt the negative feed­
back within the hypothalamic-pituitary-ovarian 
axis at the pituitary level. Follicle stimulating hor­
mone (FSH) and luteinizing hormone (LH) secre­
tions are suppressed. ovarian follicular develop­
ment and ovulation are inhibited. and the 
secretion of ovarian estrogen and progesterone 
is reduced. The inherent estrogenic and pro­
gestational properties of the gestogens initially 
stimulate endometrial growth and induce decid­
ual change within the endometrjal tissue. Sub­
sequently, amenorrhea and gradual atrophy of 
the uterine and ectopic endometrial tissue re­
sults in symptomatic relief. Pseudopregnancy 
regimens have been reported to provide symp­
tomatic relief in up to 94% of patients and a 
corrected pregnancy rate after treatment as 
high as 50%.'' The return of symptoms and the 
recurrence of endometriosis after therapy ap­
pear to increase progressively with the length of 
follow-up unless menopause ensues. The side 
effects of gestogen therapy include nausea, 
mastodynia, vaginal discharge, fluid retention, 
breakthrough bleeding, and on occasion, 
thromboembolism. Pseudopregnancy regimens 
should be avoided in patients with a history of 
thromboembolic disease and breast or endome­
trial carcinoma. 
Danazol, a weak synthetic testosterone, 
has antigonadotrophic properties similar to the 
gestogens. It is capable of inducing a pseudo­
menopausal state with its associated amenor­
rhea and endometrial atrophy but is unasso­
ciated with many of the undesirable side effects 
of gestogen therapy. Danazol suppresses FSH 
and LH secretion and therefore inhibits follicular 
development, ovulation, and corpus luteum for­
mation. Ovarian estrogen and progesterone se­
cretion is reduced to a minimum, causing endo­
metrial atrophy and amenorrhea. This inactivity 
and atrophy of ectopic endometrial tissue al­
lows reabsorption and healing Side effects of 
danazol therapy include the vasomotor symp­
toms of menopause, weight gain, edema, vagi-
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nal spotting, and acne. Fortunately, significanl 
androgenic effects are rare as the usual anti­
gonadotrophic dose required for the treatmenl 
of endometriosis is approximately one third thal 
capable of causing masculinization in the 
woman. Symptomatic improvement with thE 
danazol-pseudomenopausal regimen is re­
ported in up to 92% of patients Clinical im­
provement is noted in approximately 60% and 
a corrected pregnancy rate of 50% is said to 
exist. Unfortunately, the recurrence of symp­
toms is relatively high after discontinuance ol 
therapy. As with the pseudopregnancy regimen, 
conception after therapy prolongs the asympto­
matic interval. 
Moderate involvement with endometriosis 
is best treated with laparoscopic minisurgery fo, 
the lysis of adhesions, freeing of the ovaries, 
and cauterization of implants; a more extensive 
laparotomy may be required. Conservative sur­
gery, in cases of moderate and severe in­
volvement with endometriosis, is undertaken in 
an effort to correct reflux menstruation, relieve 
pelvic pain. and improve fertility. It consists pri­
marily of lysis of adhesions, the excision or de­
struction of all discernable endometriotic im­
plants and cysts, and is often accompanied by 
uterine suspension and presacral neurectomy in 
an effort to prevent subsequent retrofixation ol 
the uterus and provide relief of pelvic pain Con­
servative surgical approaches have been shown 
markedly to improve symptoms and child­
bearing potential. The addition of a pseudo­
pregnancy regimen to surgery, although recom­
mended by some, has in most cases not 
significantly added to the success of the opera, 
lion as measured by subsequent pregnancy o 
reducing the need for future surgery Approxi 
mately one quarter of patients undergoing con 
servative surgical therapy for endometriosis wil 
require future operative procedures because o 
endometriotic involvement. 5 
In severe cases of endometriotic in 
volvement, "radical" surgery, such as total ab 
dominal hysterectomy and bilateral salpingo· 
oophorectomy, may offer the only hope of c 
cure. II this is not an acceptable alternative fo1 
the particular patient, the physician should real­
istically think in terms of palliation rather than 
cure. The growth of ectopic endometrial tissu� 
cannot be permanently eradicated as long as 
functioning ovarian tissue remains within th� 
body Castration causes the involution an� 
death of active foci of endometriosis; however, 
the patient may still be left with fibrotic adhe­
sions and other residua which continue as a 
source of chronic pain. In selected cases, it 
may be advisable to follow a surgical approach 
to the treatment of endometriosis with a 
pseudopregnancy or pseudomenopausal regi­
men for the continued suppression of residual 
disease. 
Hormonal therapy for the surgically-in­
duced menopause may be required. If this can 
be anticipated, it is best to be sure that all foci 
of disease are removed at the time of surgery 
and not to depend upon castration alone to in­
activate residual disease. 11 au endometriosis 
has been removed, the patient may be started 
on conjugated equine estrogen. If it is thought 
that some endometriosis remains, it is best to 
delay hormonal therapy for six months or treat 
the patient for that period of time with me­
droxyprogesterone acetate; subsequently con-
jugated equine estrogen therapy may be insti­
tuted on a cyclic basis. 
Table 2 is adapted from Obstetrics and Gynecology 
(42: 19-25. 1973). 
REFERENCES 
1. SAMPSON JA: Perforating hemorrhagic (chocolate) cysts 
of the ovary. Arch Surg 3:245-323. 1921 
2. RIDLEY JH: The histogenesis of endometriosis. Obster 
Gynecol Surv 23: 1-35. 1968. 
3. ACOSTA AA, BUTTRAM VC, BESCH PK, ET AL: A pro­
posed classification of pelvic endometriosis. Obstet 
Gynecot 4219-25. 1973. 
4. SoTAEL G. DMOWSKI WP: Endometriosis and its manage­
ment. Obstet Gynecot Digest. June 1976. 
5. ANDREWS WC. LARSEN GD: Endometriosis: Treatment 
with hormonal pseudopregnancy and/or operation. Am 
JObstetGyneco/118:643-651, 1974. 
HURT ANO WERTHEIM: ENOOMETRIOSIS / 35 
Urinary Incontinence in Women 
J. ANDREW FANTL, M.D. 
Assistant Professor, Department of Obstetrics and Gynecology, Medical College of Virginia, Health 
Sciences Division of Virginia Commonwealth University, Richmond, Virginia 
INTRODUCTION 
The adult bladder and urethra acting as a 
unit allow for the voluntary dual function of urine 
collection and evacuation. Urinary continence is 
an acquired, "learned" state, and normal anat­
omy and function of the nervous and gen­
itourinary systems are necessary to maintain it. 
Urinary incontinence is defined as ··a condition 
where involuntary loss of urine is a social or hy­
gienic problem and is objectively demon­
strable.''' 
This definition takes into account both 
sociocultural aspects and the need for objective 
clinical assessment of urinary leakage. Marked 
individual variations in physical activity, occupa­
tion and hygienic standards call for appropriate 
clinical judgment when evaluating this condi­
tion. Although excessive vaginal discharge may 
be confused with urine loss, incontinence is of­
ten evoked to obtain psychologic or socioeco­
nomic secondary gains. The element of the re­
producibility is therefore of marked clinical 
importance. Eleven percent of patients eval­
uated in our urodynamic unit at the Medical Col­
lege of Virginia had no objective evidence of uri­
nary leakage during their evaluation. 
TYPES, INCIDENCE, AND PATHOPHYSIOLOGY 
The types and incidence of urinary in­
continence in females seen in our unit are 
shown in Table 1. 
Extraurethral incontinence such as fistulae 
and congenital anomalies, or incontinence due 
to neurologic conditions will not be included in 
the following discussion. 
Correspondence and reprint requests to Dr. Andrew 
Fanti. Box 34, Medical College of Virginia. Richmond. VA 
23298. 
36 / FANTL: URINARY INCONTINENCE IN WOMEN 
"Stress Urinary Incontinence" (SUI) 
Stress urinary incontinence accounts for 
approximately 56% of the cases referred to our 
unit. This is a condition in which "involuntary 
loss of urine occurs when the intravesical pres­
sure exceeds the maximal urethral pressure in 
the absence of detrusor activity." It should be 
differentiated from the symptom of SUI, which 
refers to data obtained from the history, and the. 
sign of SUI, which indicates the physician's ob· 
servation of the leaking episode.' 
It is not uncommon for otherwise healthy 
women to have occasional episodes of SUI' 
Conditions such as acute respiratory infec· 
lions or asthmatic attacks can also precipi· 
tale episodes of SUI, which disappear after 
the acute situation subsides. 
A sudden increase in intra-abdominal 
pressure causes urine to flow from the bladder 
through the urethra to the exterior. The mosi 
common single cause for this condition is an ex· 
Ira-abdominal location of the proximal urethra 
or bladder neck below the pelvic diaphragm be 
cause of loss of support or inadequate suppon 
to the retrosymphysis pubis. Atrophic and/or 
traumatic destruction of the puboprostatic liga· 
ments (Zacharin) is responsible for this ana· 
tomic pathology As a result of this anatomic sit· 
uation any sudden increase in intra-abdominal 
pressure is transmitted unequally to both blad· 
der and proximal urethra and results in urinary 
leakage. 
Other factors which may contribute to 01 
be of primary importance in, depending on indi· 
victual cases, may increase intravesical pressure 
and/or decrease urethral resistance in the ab· 
sence of detrusor activity (Table 2). It is impor· 
tant to determine in each patient which of these 
factors contributes and to what extent in the de­
velopmen! of the condition of SUI. 
Idiopathic Detrusor Instability (IDI) 
(Detrusor Dysynergla-Unstable Bladder­
Urge Incontinence) 
Before "toilet training," infants have no 
voluntary control of their bladder. It contracts 
spontaneously upon reaching a certain urinary 
volume. Adults, through a "learned" process, 
can supress this autocontractibility and void 
only when convenient. Cortically controlled in­
hibitory impulses affect lower neurologic re­
flexes rendering the bladder "stable" or "asy­
nergic. "3 During bladder filling, the intravesical 
pressure remains constant and no involuntary 
detrusor contractions occur.• Increased tension 
in the bladder wall stimulates proprioceptive re­
ceptors which send impulses that reach the cor­
tex, producing the sensation of urinary urge. By 
voluntarily removing these inhibitory cortical im­
pulses the detrusor muscle contracts and void­
ing is established. 
The detrusor muscle is considered un­
stable when uninhibited detrusor contractions 
exceeding 1 5cm/H20 pressure occur during 
cystometric evaluation. This intravesical pres­
sure elevation must be independent of any in­
crease in intra-abdominal pressure and must 
occur while the patient is asked to inhibit.' 
During adulthood, several conditions such 
as urinary tract infections, tumors and stones of 
the lower urinary tract and neurologic disorders 
can alter the normal "stability" of the detrusor 
muscle. When the instability is severe enough to 
create intravesical pressure that exceeds the 
urethral resistance, the patient becomes in­
continent. Most commonly the presence of de­
trusor instability exists in the absence of recog­
nizable urologic or neurologic conditions. A 
patient with detrusor instability may therefore be 
continent as long as the urethral resistance is 
sufficient to counteract the increase in intra­
vesical pressure. 
C. Paul Hodgkinson in 1 963 first de­
scribed this condition which represented 8% of 
incontinent patients evaluated in his service. 3 
Multiple reports since then indicate incidence 
varying from 8% to 60%,3 5. This wide range 
may in part be the result of different study popu­
lations, the lack of strict diagnostic criteria, and 
the standardization of evaluating techniques. In 
our series, 25% to 30% of patients with lower 
urinary tract symptoms have detrusor instability, 
and of these 98% are idiopathic in origin. 
Detrusor instability may present clinically 
TABLE 1 
Types and Incidence of Female Urinary Incontinence 
Ob-Gyn Urodynamic Unit 
1976-1979 
N % 
Stress Urinary Incontinence (SUI) 183 55.96% 
Oetrusor instability 
a) Idiopathic (101) (70) 79 24.16% 
b) Secondary to urinary infection (9) 
Mixed (SUI) + (101) 15 4.59% 
Psychogenic 10 3.06% 
Fistulae 3 0.92% 
No objective incontinence 37 11.31% 
327 100.00 
with or without incontinence as described 
above. Offen symptoms are associated with it 
as shown in Table 3. 
Detrusor contractions producing in­
continence can be preceded by a strong desire 
to void (Fig 1 ) or can occur without symptoms 
(Fig 2). In addition detrusor contractions may 
coincide with a strong desire to void and not re­
sult in incontinence (Fig 3). Basically all three of 
these cases represent examples of idiopathic 
detrusor instability and have the same under­
lying pathophysiology. This is a decrease in or 
lack of cortical inhibitory impulses to the spinal 
reflex centers.• 
It should be noted that in more than 50% 
of cases in our series, detrusor instability was 
only observed after "provocative" testing 
(forceful coughing or heel bouncing). Cys­
tometric techniques useful in the detection of 
this disorder should allow the patient to perform 
TABLE 2 
Factors Influencing lntraveslcal Presaure and Intra 
Urethral Resistance In the Absence of Detrusor 
Contractions. 
A. FACTORS THAT INCREASE INTRAVESICAL PRESSURE 
Abdominal Pressure 
{ 
1 . Abdominopelvic tumors 
Increment 2. Obesity 
3. Chronic pulmonary 
obstructive disease 
Vesical Tone 
Increment 
Increased Urinary 
Volume 
{ fl-Adrenergic block 
(propranolol) 
{ I . Urinary retention 
(overflow incontinence) 
2. Bad voiding habits 
8. FACTORS THAT DECREASE URETHRAL RESISTANCE 
1 . Urethral denervation (post-surgical) 
2. a-adrenergic block (phenoxybenzamine) 
3. P-adrenergic stimulation (isoproterenol-isoxuprine) 
4. Urethral fibrosis (post-surgical radiation) 
5. Hypoestrogenism 
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TABLE 3 
Symptoms Associated with Idiopathic 
Detrusor Instability 
Incontinence 51 + 
Urgency-frequency 39+ + 
Nocturia 38 
Oysuria 3 
+ 20 patients with incontinence had no symptoms 
+ + 1 9 patients with urgency-frequency had no in­
continence 
comfortable "provocative" maneuvers while in 
the erect position. Several cases will remain un­
diagnosed if these techniques are not used. 1·• 
Psychogenic Incontinence 
This type of incontinence is usually part of 
a psychological condition. These individuals 
contract the voluntary muscles of the abdominal 
wall, producing what is viewed by them as "in­
voluntary urine loss.·· Cystometric techniques 
which independently monitor intra-abdominal, 
(rectal) and intravesical pressures will record the 
coincidental elevation of both pressures 9 
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Fig. 1-ln this case an automatic detrusor contraction oc­
curred ten seconds after a cough (C). There was no evi­
dence of pressure increment in either the urethral or rectal 
leads. There was a strong desire to void prior to the detrusor 
contraction, and there was evidence of urine leakage. 
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Fig. 2-ln this case an automatic detrusor contraction oc· 
curred six seconds after a heel bounce (HB) and showed 
only in the bladder lead. There was incontinence of unne 
(leakage - L) and no urge sensation. 
DIFFERENTIAL DIAGNOSIS 
History 
The time of onset and the circumstances 
surrounding it may be of help in establishing the 
diagnosis. Incontinence since childhood can in­
dicate congenital anomalies such as ectopic 
ureter or if it follows surgery and/or radiation 
therapy, it may be related to genitourinary fis­
tulae. 
The majority (96%) of patients with urinary 
incontinence have SUI or 101, or a combination 
of both. Table 4 compares the most common 
symptoms of patients with SUI and IOI. 
Physical Examination 
A comprehensive examination with spe­
cial attention to the genitourinary system is. 
mandatory. Special aspects of the pelvic exami­
nation should include: 
a) Assessment of the bulbocavernosus 1 
reflex. This is done with the patient in 
the lithotomy position by gently com-
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Fig. 3-This case shows an automatic detrusor contraction 
occurring five seconds after a cough (C). There was a pres­
sure increment in the urethral lead but none in the rectal 
lead. The detrusor contraction did not produce leakage of 
urine. There was a strong desire to void simultaneous with 
the detrusor contraction. 
pressing or touching the clitoral 
glands. I f  the lower spinal cord reflex 
(S, to S,) is intact, contraction of the 
anal sphincter is observed. 
b) Inspection and palpation of the anterior 
vaginal wall. It is preferable to use a 
Sims speculum on the posterior wall 
for proper visualization. The external 
urethral meatus should be inspected, 
and the presence of a urethral divertic­
ulum and sensitivity of the trigonal area 
should be assessed. Changes in the 
entire anterior vaginal wall during max­
imal straining should be noted. 
c) Assessment of pubococcygeus tone. 
This can be performed by placing two 
fingers over the posterior vaginal wall 
and asking the patient to elevate or 
squeeze the examiners fingers. Pub­
ococcygeus tone may be improved 
with exercises and may help in the 
management of certain cases of SUI. 
Special Diagnostic Studies 
Once the preliminary evaluation through a 
history and physical examination has been 
completed, special studies may help to confirm 
the diagnosis. 
If a neurologic disease is suspected, fur­
ther evaluation by a neurologist is indicated 
prior to completion of the incontinence work-up. 
Intravenous pyelography is indicated if 
any congenital conditions are suspected or if 
upper urinary tract pathology is suspected. 
Determination of residual volume, sedi­
ment, and a bacteriologic evaluation for infec­
tion should be done prior to further evaluation. 
Infection can cause detrusor instability and in­
continence. Large urinary residuals may be 
present in obstructive uropathies and atonic 
bladder dysfunctions because of neurologic dis­
orders. 
TABLE 4 
Comparison of Common Symptoms and Signs In Patients 
with SUI and IDI 
Onset 
Remissions 
Sensation of incomplete voiding 
Urgency and frequency of 
urination 
Dysuria 
Nocturia 
Bed-wetting 
Characteristic type of leak 
Situations surrounding 
the leaking episode 
SUI 
Usually gradual 
Not usually 
Not common 
No 
No 
No 
No 
··spurt" 
At the ··acme·· of a forceful 
valsalva maneuver, without 
concomitant symptoms. 
IOI 
Usually sudden 
Usually 
Common 
Yes 
No 
Yes 
Occasionally 
··stream" 
Spontaneously or several 
seconds after a valsalva 
maneuver or positional change. 
Usually with sensation of urge but 
not always. 
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Urethroscopy 
This procedure should be performed, in 
our view, on all patients with incontinence, es­
pecially those with symptoms of urgency. Spe­
cific information obtained during urethroscopy 
should include: 
a) urethral length and calibration, 
b) inflammatory and trophic changes of 
the urethra and trigone 
c) presence of urethral lesions, fistulae or 
diverticulum, 
d) observation of the proximal sphincteric 
mechanism during retrograde filling 
and while bearing down, and 
e) observation of the urethral orifices and 
trigonal area. 
Bonney-Read Test or Vesical Elevation 
Test 
Through a red rubber or Foley catheter, 
body temperature water or saline is instilled into 
the bladder until the patient expresses desire to 
void. The volume is noted, and the catheter re­
moved, and the patient asked to cough hard; 
any leakage is noted. Subsequently, the proce­
dure is repeated while elevating the anterior 
vaginal wall, being careful not to compress the 
urethra against the symphysis erect. Care 
should be taken to use similar volumes every 
time and the patient should not bend her knees 
while coughing. This prevents the extrinsic (vol­
untary) urethral closure mechanism from be­
coming inadvertently relaxed during maximal 
stress. Urinary leakage in spurts, occurring si­
multaneously with the cough, and disappearing 
while elevating the bladder neck, strongly sup­
ports the diagnosis of SUL 
Cystometry 
This procedure allows for the evaluation of 
the detrusor muscle during bladder filling It is 
basically a method of which the pressure-vol­
ume relationship of the bladder is measured, 
and the "stability" of the bladder ascertained. 
The access or route to bladder filling may be 
transurethral, percutaneous or orthograde. The 
medium may be liquid or gas, used in continu­
ous or incremental filling rates. The position of 
the patient can vary from sitting or lying, to 
standing. 
In our unit we use the method which C. P. 
Hodgkinson published in 1963.' Direct elec­
tronic cystometry allows for slow, orthograde 
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filling of the bladder with the subject's own 
urine Small electronic transducer catheter� 
placed in the urethra, bladder, and rectum 
transmit independent pressure readings and al: 
low this study to be performed in any desirabl� 
position with no discomfort. 
Stability of the detrusor muscle should 
specifically be tested in the erect position and 
after "provocative" maneuvers such as forceful 
coughing or heel bouncing. As mentioned 
above, if the chosen method of cystometry does 
not allow for this provocative testing, 50% or 
more of cases will remain undiagnosed.' 8 In our 
experience direct electronic cystometry remains 
the single most important diagnostic technique 
in the detection of detrusor muscle instability. 
Metallic Bead-Chain Cystourethrography 
This technique was described by C. P. 
Hodgkinson in 1953. 10 
A metallic bead-chain is placed in the ure­
thra and radiopaque medium is instilled in the 
bladder and vagina. Lateral and anteroposterior 
radiographic views are obtained, in the erect 
position at rest and during straining. 
Specific observations common to patients 
with SUI have been described. These include: 
a) Loss of posterior urethrovesical angle (PUV 
<) (Fig 4b); b) abnormal inclination of urethra 
axis in addition to the loss of the PUV <) (Fig 
4c)11 ; c) the urethrovesical junction becomes 
the most dependent position of the bladder 
base during strain (Fig 4d) 10 
Although these observations are seen in 
cases of SUI, they are also present in cases of 
IOI. The overlap impedes the use of this tech­
nique for the differential diagnosis between 
these types of incontinence. In our unit the tech­
nique has been useful in the: 
a) preoperative identification of the ana­
tomic relationship between the sym­
physis pubis, bladder base, urethra 
and anterior vaginal wall. These can 
not be satisfactorily assessed by 
simple observation during pelvic ex­
amination. 
b) prognostic assessment, based on de­
gree of descent of the urethrovesical 
(UV) junction. The lower the UV junc­
tion preoperatively, the better the 
chance to elevate it with surgery. 
c) postoperative evaluation of the surgi­
cal technique 
d) reevaluation of the reoccurence of 
symptoms of incontinence. 
TREATMENT 
SUI 
It is imperative to evaluate the contributory 
factors and to what extent they influence the in­
continent condition. Weight reduction, change 
in voiding habits, and discontinuation of ad­
verse medication may cause rapid improvement 
in the patient. Perinea! exercises such as those 
devised by Kegel can have remarkable success 
in treating SUI, especially in patients with mod­
erate-to-good pubococcygeus tone. 
All the surgical procedures described for 
the treatment of SUI place the proximal urethra 
to an intra-abdominal location. This restoration 
to a location above the pelvic diaphragm can be 
accomplished either vaginally or suprapubically. 
There is a tendency to do more suprapubic pro­
cedures in view of results showing better long­
term follow-up when this route has been cho­
sen. However, it is wise to evaluate each case 
individually where surgery is indicated rather 
than establish fixed protocols. 
IDI 
Anticholinergic Therapy. Several anti­
cholinergic preparations have been used with 
success. These drugs will block cholinergic 
preganglionic synapsis of the parasympathetic 
fibers in the detrusor muscle. The need for con­
stant oral medication and the side effects ob­
served with some of the doses needed make its 
use clinically unsatisfactory. 
Bladder Drills 
Bladder retraining techniques have been 
used with good results.• Patients are instructed 
to void on predetermined schedules, prolonging 
progressively the intervals between voidings. 
This drill reestablishes the cortical inhibition of 
the bladder reflex by repeating the process of 
training. Similar programs have been utilized in 
hospitalized patients and cortical control has 
been achieved through biofeedback mecha­
nisms. This form of management seems prefer­
able to either drug therapy or drastic bladder 
denervation through surgical intervention. 
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Fig. 4--Specific urethrovesical relationships observed in 
patients with SUI. 
CONCLUSION 
Female urinary incontinence is a complex 
problem. Thorough physical examination to­
gether with diagnostic techniques such as ure­
throscopy and cystometry will avoid unneces­
sary surgery and diminish treatment failures. If 
surgery is indicated, the skilful surgeon should 
assess each patient individually and perform the 
procedure best suited to that particular patient. 
Figures 1 , 2 and 3 are reproduced by permission from 
the American Journal of Obstetrics and Gynecology 
(129 299-000, 1977) 
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Cervical Cytology and Colposcopy 
W GLENN HURT, M.D. 
Department of Obstetrics and Gynecology, Medical College of Virginia, Health Sciences Division of 
Virginia Commonwealth University, Richmond, Virginia 
Colposcopy was first described by Hinsel­
mann of Hamburg in 1925. The colposcope is 
a binocular microscope of low power ( 1 Ox to 
25X} which contains a light source and is 
mounted on a stand to permit its use in the 
study of the surface of the uterine cervix. Using 
the colposcope, the physician can identify and 
evaluate cervical epithelial abnormalities. 
Cytology, as a means of diagnosing cervical 
cancer, was introduced to clinical medicine by 
Doctors Papanicolaou and Traut of New York in 
1943. With improvements in technique and 
specificity, cervical cytology has become the 
most practical and effective means of screening 
for preinvasive and early invasive cancer of the 
uterine cervix. 
In the past, colposcopy and cytology have 
been considered to be competitive diagnostic 
techniques. Now, they are being used in a com­
plementary manner to improve diagnostic accu­
racy, determine therapy, and evaluate results. 
Their combined use has significantly decreased 
the need for cold knife conization of the cervix 
thereby reducing morbidity and costs. 
As most cervical neoplasia develops about 
the squamocolumnar junction of the cervix, the 
following discussion will include a review of the 
biological activity of the area, brief mention of 
the cytologic sampling technique, the evolution 
of colposcopic patterns, and the presentation of 
a schema for the combined use of cervical cy­
tology and colposcopy in the diagnosis and 
management of cervical neoplasia. 
Correspondence and reprint requests to Dr. W. Glenn 
Hurt, Box 34, Medical College of Virginia, Richmond, VA 
23298. 
Transformation Zone 
During childhood and the reproductive 
years the squamocolumnar junction of the uter­
ine cervix is usually located on the vaginal por­
tio. Changes in vaginal pH, trauma, and other 
local environmental factors cause the multi­
potential reserve cells underlying the columnar 
epithelium to undergo squamous metaplasia 
and the basal cells of the squamous epithelium 
to proliferate in order to replace the more fragile 
columnar epithelium with a more resistant 
squamous epithelium. As these processes are 
continuous, the squamocolumnar junction tends 
to retreat within the distal endocervical canal. 
Therefore, the majority of premenopausal 
women will have the squamocolumnar junction 
of their cervix located on the vaginal portio while 
postmenopausal women are more likely to have 
the squamocolumnar junction of their cervix lo­
cated within the distal endocervical canal where 
it is less accessible to direct visual examination. 
The squamocolumnar junction and the 
surrounding areas of active squamous meta­
plasia combine to make up the transformation 
zone. Typical squamous metaplasia implies that 
the process is orderly and predictable, resulting 
in the production of normal squamous epithe­
lium. Occasionally, atypical squamous meta­
plasia takes place. Some of the resultant atypi­
cal epithelium resists further change and 
persists as such or is replaced at a later date by 
normal squamous epithelium. That which is less 
resistant to change may progress, in an orderly 
sequence, through the various stages of dys­
plasia to carcinoma in situ and even to invasive 
carcinoma of the cervix. At this time there is no 
practical means of determining which atypical 
lesion will regress, persist, or progress to ad-
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vanced neoplasia. Therefore, the identification 
of any degree of cervical neoplasia requires in­
vestigation and eradication if it§ course is to be 
interrupted Fortunately, cervical intraepithelial 
neoplasia (CIN) develops over a long enough 
period of time to permit its detection, documen­
tation, and eradication. The complete removal 
of the lesion prevents its progression to invasive 
carcinoma. New recurrences appear to repeat 
the developmental sequence from the begin­
ning, rather than initiating it at a more advanced 
stage. 
Cervical Cytology 
Care should be exercised in obtaining the 
best possible specimen for cervical cytology 
The endocervical canal should be aspirated in 
order to obtain an endocervical specimen; then 
a thorough abrasive scraping of the entire trans­
formation zone should be performed using a 
plastic spatula shaped to conform to the ex­
ternal cervical os. Immediate smear preparation 
and fixation reduce artifacts. After appropriate 
staining, it is possible for the cytopathologist to 
evaluate the smear and classify the findings, us-
ing cytologic terminology, as normal, atypical 
dysplastic (mild, moderate or severe), care: 
noma in situ, microinvasive, or invasive cart,. 
noma. The diagnosis can be highly accurate 
and lesion specific Often cervical and vagilii, 
infections can be diagnosed by cytologic exam 
ination which, if recognized, should be reporte0 
to the clinician. All patients with evidence of ce1 
vical neoplasia on cytologic screening are can 
dictates for colposcopy. 
Colposcopy 
The colposcope is used to visualize the 
portio and identify lesions recognizable because 
of alterations in vasculature, surface contour 
color and opacity. Research has shown that 
most cervical neoplasia is unifocal in origin and 
that lesions which exhibit these alterations are 
the same ones that are responsible for the ab­
normal cytologic smears. 
During the process of normal squamous 
metaplasia the vascular bundles which serve 
the columnar epithelium usually recede and 
form a flattened vascular layer underlying the 
new mature squamous epithelium. In the case 
TABLE 
Cervical Cytology 
Dysplasia, Carcinoma in situ. Invasive Carcinoma 
I 
Repeat cytology 
Colposcopic examination 
Directed cervical biopsy 
Endocervical curettage 
Extent of lesion not seen --- -- - - ----'-- - --- --- Extent of lesion seen 
Positive endocervical curettage 
Microinvasive carcinoma 
No lesion but abnormal smear 
I 
Cold knife conization 
Fractional dilatation and curettage 
Cervical intraepithelial 
neoplasia 
No additional Hysterectomy 
therapy 
Microinvasive 
carcinoma 
I 
Hysterectomy 
Invasive 
carcinoma 
I 
Radiation/Surgical 
therapy 
Frequent follow-up examinations are indicated after therapy for cervical neoplasia. 
4 4 / HURT CERVICAL CYTOLOGY AND COLPOSCOPY 
Cervical intraepithelial 
neoplasia 
Cryosurgery Cold knife Hysterecl� 1 
conization 
of cervical neoplasia, these vascular bundles 
persist among the clones of neoplastic cells. 
The evolution of colposcopic patterns is the re­
sult of layers of nuclear dense neoplastic cells 
covering up or distorting the vasculature to the 
surface epithelium. If neoplastic cells form lay­
ers across the top of the vascular bundles, the 
surface epithelium loses its pinkish color; if this 
epithelium is treated with 3% acetic acid, its 
metaplastic cells take on a white appearance. 
This colposcopic picture is referred to as white 
epithelium On occasion, the neoplastic cells 
will form cuffs about the vascular bundles, and 
the tips of the vessels within the bundles will un­
dergo dilatation. The resultant colposcopic pic­
ture is one of stippling or punctation. As these 
vascular bundles are connected by smaller ves­
sels so as to form vascular baskets, and as neo­
plastic cells crowd within and about all these 
vessels, the dilated tips of the vascular bundles 
and the interconnecting vessels may both be 
visible giving the colposcopic picture of a mo­
saic. White epithelium, punctation, or the mo­
saic pattern may be seen singly or in combina­
tion, and to a lesser or greater extent.  
Experience enables the colposcopist to grade 
these findings into CIN I (minimal or mild dys­
plasia), GIN II (moderate dysplasia), or CIN Ill 
(severe dysplasia or carcinoma in situ). All le­
sions should be mapped in the patient's chart 
and biopsied. Endocervical canal curettage is 
recommended. To avoid inappropriate therapy, 
no patient should be treated solely on the basis 
of cytologic and/or colposcopic findings. It is 
essential to know the limits of all lesions and to 
have histologic documentation of each. 
Correlation of Data 
. Cytologic, colposcopic, and histologic 
diagnosis must be in agreement in order to pro-
ceed with therapy. It must be remembered that 
although the volume of tissue obtained by cer­
vical biopsy is larger than that obtained by cyto­
logic sampling, the latter has the capability of 
sampling a more extensive area of the cervix. 
As cytologic and histologic diagnoses are lesion 
specific, receipt of a more advanced diagnosis 
of cervical neoplasia on cytologic examination 
than on histologic examination could mean that 
the most advanced lesion was not recognized 
colposcopically and therefore escaped biopsy. 
Should this occur a repeat colposcopic exami­
nation with directed biopsy or cold knife con­
ization of cervix should be performed. 
Using the schema in the Table, it is pos­
sible to combine the use of cervical cytology 
and colposcopy to identify histologically the 
most advanced cervical lesion in approximately 
90% of cases. Conization of the cervix is still re­
quired when no cervical abnormalities consis­
tent with the cytologic abnormality are found, 
the extent of the lesion cannot be ascertained, 
endocervical canal curettings are positive for 
neoplasia, or microinvasive cancer of the cervix 
is diagnosed. Failure to perform a cold knife 
conization and fractional dilatation and curett­
age in such cases may result in failure to detect 
the most advanced stage of cervical neoplasia 
or to appreciate the extent of disease. This has 
been a cause for inappropriate therapy and 
subsequent recurrence of cervical intraepithelial 
neoplasia and carcinoma. 
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Off ice Endometrial Sampling 
STEPHEN A. COHEN, M.D. 
W GLENN HURT, M.D. 
Department of Obstetrics and Gynecology, Medical College of Virginia, Health Sciences Division of 
Virginia Commonwealth University, Richmond, Virginia 
The concept of office endometrial sam­
pling is not new. Kelly recommended its use in 
1925.' More recently, the procedure has re­
ceived increased attention as physicians and 
the public have sought ways to curb the spiral­
ling cost of medical care. Uterine curettage is 
the operation most commonly performed on 
women throughout the world. As an inpatient 
procedure, it costs $500 to $600. The same 
procedure performed in an outpatient surgical 
center costs $350 to $400. In over 90% of 
cases, an adequate endometrial sample may be 
obtained in the office at a cost of $50 to $60. 
For office endometrial sampling to be accept­
able to the physician, it must be simple to ac­
complish, relatively inexpensive to use, and 
agreeable in terms of patient comfort and mor­
bidity The specimen obtained should be repre­
sentative of the entire endometrium, adequate 
for pathological study, and easily preserved, 
transported, and processed. 
Indications for office endometrial sampling 
are given in the Table. In the adolescent female 
there is rarely an indication for endometrial sam­
pling; however, during the reproductive years 
and thereafter, there are frequent indications for 
sampling. As the endometrium is extremely sen­
sitive to systemic levels of the sex hormones. 
estrogen and progesterone, sampling will help 
determine ovarian function and give indirect evi­
dence of the status of the hypothalamic-pitui­
tary-ovarian axis. Ovulation is usually followed 
by corpus luteum formation. The corpus luteum 
Correspondence and reprint requests to Or. Stephen 
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produces progesterone and causes the endo­
metrium to take on a secretory appearance 
Timed endometrial sampling may be used to 
prove ovulation and evaluate corpus luteum 
function. A delay in the maturation of the endo 
metrium may be taken as evidence of an in­
adequate corpus luteum. Persistence of a pro/ii, 
erative endometrium, without the development 
of a secretory component, is evidence of ano­
vulation. The documentation of anovulation 01 
of inadequate corpus luteum function is impor· 
tant information in an infertility work-up. Chronic 
anovulation with prolonged stimulation of the 
endometrium by unopposed estrogen can lead 
to the development of endometrial hyperplasia 
This is a common cause of abnormal uterine 
bleeding Severe hyperplasia, of the adenoma­
tous or atypical variety, is considered a pre· 
cursor of endometrial carcinoma. Endometnal 
sampling may be used to evaluate the results ol 
hormonal therapy whether it be for the induction 
of ovulation, the eradication of endometrial hy· 
perplasia, or as replacement therapy to control 
the vasomotor symptoms of the menopause. 
The obese. hypertensive, and diabetic patient 
who is considered to be at increased risk for the 
development of endometrial carcinoma. or the 
patient with abnormal endometrial cytology, 
may undergo sampling as a screening proce­
dure in an effort to detect the presence of a pre· 
malignant or malignant condition. 
Absolute contraindications to endometriat 
sampling are acute pelvic infection and preg· 
nancy, if abortion is not desired. Relative con· 
traindications include an inadequate pelvic ex· 
amination, cervical stenosis, marked anterior or 
posterior uterine flexion, and clotting defr· 
ciencies. 
Techniques for sampling the endometrium 
usually produce either a cytologic or a histologic 
preparation. Cytologic preparations, in general, 
are less desirable than histologic preparations 
as they are mme difficult to interpret This is es­
pecially true in lhe detection and grading of 
neoplasms of the endomelrium. Most patholo­
gists are more comfortable u·s.ing histologic 
preparations for the evaluation of endometrial 
disease. 
There are two uterine curetles commonly 
used for office endometrial sampling. The No­
vak curette was developed in 1 91�i, and the 
Vabra Aspirator (Cooper Laboratories, Inc, 
Wayne, New Jersey) in l 96S. Both obtarn histo­
logic specimens. 
The Novak curette has a metal cannula of 
5 mm diameter and a rectangular, serrated' 
opening just proximal to its distal end. A syri.nge 
may be placed on the pro)(iimal er:wl ot the No­
vak curette in order lo apply Sl!!Ction ag.a'msl the 
endometrial lining and improve samphng. The 
Novak curette is especially wen adapted. to ob­
taining endometrial strips f.rom v,arious q1Jad· 
rants of the endometrial cavity for u-se in dating 
the endometrium in order to prove ovulation and 
evaluate corpus luteum function. Kahler, in 
1 969, presented a series of 1 60 patients in 
which he compared biopsies of the endome­
trium taken with the Novak curette with sub­
sequent dilatation and curettage and hysterec­
tomy specimen analysis In his series there was 
a 96% positive correlation between the diagno­
sis obtained using the Novak curette and that 
obtained on subsequent dilatation and curett­
age or hysterectomy. 2 Hofmeister reported on 
over 20,000 biopsies using the Novak curette. 
He sampled all patients over the age of 35 on a 
routine basis and those under the age of 35 
who reported irregular menses. Seventeen per­
cent of these patients who were found to have 
endometrial carcinoma were asymptomatic at 
the time of endometrial sampling. It is on this 
basis that he states that one in five endometrial 
carcinomas are asymptomatic and will not be 
detected without routine endometrial sampling. 
Hofmeister reported an accuracy of 94% using 
the Novak curette.3 
The Vabra Aspirator comes as a dis­
posable unit consisting of a 3 mm metal can­
nula which has a rectangular curette with sharp 
lateral edges located just proximal to its distal 
lip. The metal cannula is attached to a plastic 
TABLE 
Indications for 
Office Endometrial Sampling 
Infertility work-up 
Menstrual disorde,s 
Postmenopausal bleeding 
Hormonal ther-apy 
Scieening for en.dometrial cancer 
Abnormal endometrial cytology 
Follow-up of therapy 
tissue tilter and collection con1ainer. The collec­
li.on ool'ltainer must be attache.d to a vacuum 
source supplyirig a negative pressure of approx­
imately 1. 6.0 mm Hg. With suction applied by 
the o©ClusiCi>n of holes in the proximal end of the 
cannula, the curette shoYld be swept in a rotary 
taslrli.on about the,eAtire endometrial cavity. The 
S@eci.meµ will be tr-apped in the plastic filter. 
When the procedure is completed, suction is 
dis�onneated. The cmelle is r,emoved from the 
pla&t,ic GGnt:ainer. fi�ative i.s ad.ded to the speci­
men. and ,the plastic container is capped. The 
Vat,ra Aspliator costs approximately $1 2 and is 
disposable. Discomfort caused by Vabra curett­
age has been equa1ed to that of an intrauterine 
contraception dev,ice insertion. The procedure 
has me1 with. a high degree of physician and pa­
tient acceptance. The Walter Reed Army Hospi­
tal has reported 95% accuracy in 300 cases of 
Vabra wreltage foll.owe.a by a subsequent gy­
necologic dilatation and curettage performed in 
order to compare pathologic diagnoses. In that 
series. one third of the patients were sampled 
without anesthesia and two thirds with para­
cetvical block anesthesia. The paracervical 
block anesthesia did not significantly increase 
the acceptance of the procedure, although it re­
duced the percentage of patients who reported 
that they experienced "severe" pain. Ninety­
four percent of the patients who have had both 
the Vabra curettage and subsequent gyneco­
logic dilatation and curettage stated that they 
would prefer to have the Vabra curettage rather 
than an inpatient dilatation and curettage if this 
were indicated at a future date.• 
If office endometrial sampling is to be per­
formed, the patient should be put at ease with 
an explanation of why the procedure is being 
done, how it is going to be performed, and what 
she should expect in the way of discomfort and 
bleeding. An adequate pelvic examination must 
be performed in order to determine uterine size 
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and position. A uterus which is over 8 to 1 0 
weeks gestational size is not ideal for office en­
dometrial sampling. If it is decided to proceed 
with sampling, the cervix should be cleansed 
with an antiseptic solution and a tenaculum 
placed on the anterior lip of the cervix so that 
traction will straighten the uterine canal. The 
uterus should be sounded in order to determine 
the direction and depth of the uterine canal. The 
sampling device may then be inserted and the 
specimen collected. The specimen may be pre­
served in formaldehyde solution. 
Complications associated with endome­
trial sampling are similar to those of dilatation 
and curettage but rarely require surgical man­
agement. The most frequent complications are 
uterine perforation, hemorrhage, infection, syn­
cope and pain. Drug sensitivity, if it occurs, is 
related to the use of systemic analgesia and 
paracervical block anesthesia. 
It must be emphasized that if the physi­
cian is unable to obtain an adequate tissue 
specimen or the pathologist is unable to render 
an absolute diagnosis on the tissue specimen, 
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office endometrial sampling must then be foll: 
lowed by a more thorough inpatient uterine dilai 
talion and curettage performed under anesl· 
thesia. This is to stress the fact that althoug� 
over 90% of all cases in which endometrial1 ' 
sampling is indicated can be handled as an o\ 
lice procedure, at least 1 0% of all cases need" 
ing sampling must have it performed on an in-, 
patient basis because of inadequate sampling! 
and technical or anatomical difficulties. 
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Evaluation and Management of Adnexal 
Masses 
DEAN R. GOPLERUD, M.D. 
Department of Obstetrics and Gynecology, Health Sciences Division of Virginia Commonwealth 
University, Richmond, Virginia 
The adnexa are those structures which lie 
along the uterus, the most important of which 
are the tubes and ovaries. The portions of the 
broad ligaments and mesosalpinx which con­
tain embryonic remnants may also, at times, be 
palpable and therefore must be considered in 
any differential diagnosis 
Evaluation of the Adnexal Mass 
Bimanual Pelvic Examination. The sim­
plest, least expensive, and most fundamental 
technique in evaluating the adnexal mass is a 
bimanuai pelvic examination. The normal ovary 
in a prepubertal female is usually not palpable 
and the normal postmenopausal ovary is so 
small and atrophic that it, too, is not often felt. 
The ovary in women between the ages of men­
arche and menopause, however, is about 1 Y2 
X 2 X 3 Y2 cm. The experienced examiner can 
usually feel ovaries of this size in a cooperative 
patient of average body build. 
During bimanual pelvic examination sev­
eral determinations concerning the adnexal 
mass should be made. First, size should be esti­
mated in reference to an absolute standard 
such as a centimeter ruler; comparison to fruits 
and. vegetables lacks precision and should be 
avoided. It is important to differentiate cystic 
masses from those that are solid . The location 
The follow·n · · . 
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of the mass and its position in reference to the 
uterus, rectum and bladder should be de­
scribed; mobility and tenderness on palpation 
may also be extremely important in differentiat­
ing neoplasms from inflammatory masses. 
Intravenous urogram. ultrasound, and 
computerized tomography. There are several 
technical procedures using modern medical 
technology which are available today including 
intravenous urograms, ultrasonography, and 
computerized tomography. 
An intravenous urogram will often provide 
helpful information about an adnexal mass as 
well as outline important portions of the urinary 
tract. Solid adnexal masses that are extremely 
vascular may take up the contrast material 
whereas cystic masses are not likely to do so. 
Any deviation of the bladder and ureters can 
readily be seen. The usual scout film of the ab­
domen taken prior to the injection of contrast 
material will occasionally show a tooth or por­
tion of bone most commonly associated with a 
benign cystic teratoma (dermoid cyst). 
Ultrasonography is useful in determining 
the size and location of adnexal masses as well 
as differentiating solid from fluid components of 
a mass. 
Computerized tomography is considerably 
more expensive but will precisely delineate cer­
tain characteristics of an adnexal mass, espe­
cially attachments to bladder and bowel, when 
used in combination with contrast enhancement 
techniques . 
In spite of the current interest in these 
newer screening techniques the bimanual pelvic 
exc1min:1tion is still the most pr::ictic::il mc:ins 
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whereby most adnexal masses are found and is 
the basis for most therapeutic decisions. 
Etiology 
Physiologic. The ovaries and tubes may 
be enlarged owing to a number of causes. 
Physiologic enlargement of the ovary occurs 
with the formation of the corpus luteum of men­
struation and to a greater extent with the corpus 
luteum of pregnancy. Enlargement because of 
normal cyclic function should be recognized. 
Theca lutean cysts are commonly found in as­
sociation with gestational trophoblastic disease. 
Bilateral enlargement of the ovaries is the 
usual finding in the polycystic ovary of Stein-Le­
venthal syndrome. Evaluation and treatment are 
usually medical and directed towards the under­
lying hormonal problem 
Inflammatory. Inflammatory disease in­
volving adnexal structures is due to gonorrhea, 
the most commonly reported communicable 
disease in our country today. Acute salpingitis 
of gonococcal origin may result in a tubo-ovar­
ian abscess which may occupy the entire pelvis 
These inflammatory enlargements are usually 
bilateral, tender, and are accompanied by the 
usual signs and symptoms of pelvic gonococcal 
infection. 
Neoplastic The third major category of 
adnexal masses is neoplastic which may be ei­
ther benign or malignant The benign cystic 
teratoma is the most common benign neoplasm 
of the ovary in the young adult woman. The 
identification of a tooth within the mass on a pel­
vic roentgenogram may be diagnostic, but most 
dermoid cysts are not identifiable in this man­
ner. The dermoid cyst is often bilateral and 
arises in the central portion of the ovary. As it 
enlarges the ovarian cortex is compressed. In 
dermoid cysts up to 1 0 cm or 1 5 cm in diame­
ter it is frequently possible to find a cleavage 
plane between the cyst and the ovarian sub­
stance. Ovarian conservation by cystectomy 
rather than oophorectomy may be practical. 
A paraovarian cyst arises from embryonic 
remnants within the mesosalpinx and can usu­
ally be identified because it is separate from the 
ovary The fallopian tube is often stretched 
across the cyst as the mesosalpinx is dis­
tended. In this instance, also, a cystectomy will 
preserve a functioning ovary and tube on the in­
volved side. 
Approximately 1 7,000 cases of ovarian 
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cancer are diagnosed in the United States an­
nually. Each year between 11,000 and 12,000 
women die from this disease. The majority ol 
these patients have extensive disease involving 
structures out of the pelvis at the time of initial 
laparotomy. Most ovarian cancers are epithelial 
tumors and a smaller number are of stromal and 
germ cell origin. The scope of this discussion 
does not include the total management of ovar­
ian cancer, but the importance of adequate 
evaluation at the time of initial laparotomy can­
not be overemphasized The cell type and de­
gree of differentiation of the tumor. together 
with the clinical extent of disease determined ai 
laparotomy, are critical in planning manage­
ment and forming a prognosis It is impossible 
to evaluate the upper abdomen adequately 
through a Pfannenstiel incision. While the cos­
metic advantages are obvious, the critical im­
portance of adequate staging must be the major 
consideration at the time of surgery. 
Many ovarian cysts can be removed intacl 
through an adequate incision. The ma1or advan· 
tage of the vertical midline incision is that it can 
be extended from the symphysis pubis beyond 
the umbilicus (to the xyphoid cartilage if neces· 
sary) to remove a large cyst and to satisfactorily 
explore the upper abdomen. In the patient with 
Stage Ill ovarian cancer with involvement of the 
omentum and peritoneal surfaces it is neces· 
sary to palpate and visualize the liver and d1a· 
phragm so that biopsies can be performed It is 
also important in the patient with ovarian cancer 
which appears to be grossly limited to the pelvis 
to evaluate the organs of the upper abdomen. II 
biopsies are taken from the inferior surface ol 
the diaphragm, the omentum and para-aortic 
lymph nodes, between 1 0% and 25% of pa· 
tients will be found to have microscopic disease 
even though grossly evident tumor is limited tr 
the pelvis 
The adolescent and young adult womar 
with unilateral ovarian tumor presents a uniquE 
problem It is natural for most of these patient: 
to wish to preserve their childbearing capacity 
and it is reasonable that the operating surgeor 
will respect their desire. Conservative surgen 
consisting of unilateral salpingo-oophorecton1, 
is certainly justified in young patients with Ill 
mors such as dysgerminomas and granulosa 
theca cell tumors. It is particularly important ir 
such patients. when conservative surgery is ini 
lially done, that adequate inspection and biops, 
of the contralateral ovary be carried out. It is 
usually preferable, in the young patient, to per­
form a more conservative operation if there is 
any doubt about the final pathologic diagnosis 
A more radical procedure can usually be safely 
done at a later time if careful pathologic exami­
nation proves it to be necessary 
Metastatic cancer. Ovarian cancer may 
be secondary to primary tumors in the gastroin­
testinal tract, the breast, and the endometrium 
as well as other less common sites. Usually, the 
primary site is obvious; however, in some pa­
tients with endometrioid cancer of the ovary (re­
sembling endometrial malignancy) it may be ex­
ceedingly difficult to differentiate a primary 
endometrial cancer which is metastatic to the 
ovary from a primary endometrioid cancer of 
the ovary metastatic to the uterus. 
Fallopian tube. The fallopian tube must 
also be regarded as a primary site for an ad­
nexal mass. Aside from inflammatory cond'i­
tions, ectopic pregnancy is probably the mass 
most commonly seen. The presence of pain, 
the tender mass, and the history o.f overdue 
menses together with a positive pregnancy t.est 
and blood in the cul-de-sac will often help in 
making this diagnosis 
Primary carcinoma of the fallopian tube is 
seldom suspected prior to operation Occasion-
ally, a history of intermittent watery discharge 
from the vagina and an oval-shaped pelvic 
mass are noted in cancers of the tube. 
Management Guidelines 
Certain guidelines should be kept in mind 
in evaluating adnexai masses. Any adnexal en­
largement in the postmenopausal woman 
should be an indication for removal. In the adult 
woman prior to the menopause a cystic mass 5 
cm or 6 cm in size that persists through one or 
more complete menstrual cycles is an indication 
for exploration. If the mass is enlarging during 
}hat time o.f observat.ion, the indication for sur­
g,ery is more urgent; solid, bilateral masses are 
mo.re suspicious than cystic unilateral masses. 
· F·ina,I
J.y, there are a few situations in which 
emergency exploration 1s indicated. Torsion of 
an ovafian cyst, characterized by pelvic pain of 
increasing severity, ·is often accompanied by a 
mi'ld teukocytosis and low-grade fever; the pain 
is usually ag:g.ravated by motion. Hemorrhage 
from a rnptured ectopic pregnancy demands 
immedi-a.le ·surgery as soon as the diagnosis is 
made as does a ruptured tuba-ovarian abscess; 
the latter is best treated by complete hysterec­
tomy a1nd bilateral, salpingo-oophorectomy. Fail­
ure to act promptly in such instances may result 
in g,en�ralized peritonitis. 
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Some Psychological Aspects of Dealing 
with Cancer 
JOEL J. SILVERMAN, M.D. 
Associate Professor of Psychiatry and Surgery, and Chairman, Division of Consultation/Liaison 
Psychiatry, Medical College of Virginia, Health Sciences Division of Virginia Commonwealth 
University, Richmond, Virginia 
Cancer has a potentially profound affect 
upon the emotional and physical life of the pa­
tient and his or her family. For most people the 
word "cancer" has a fearsome connotation. 
This discussion explores the areas of self­
image, body-image, and personal relationships 
that are often altered in cancer patients, as well 
as the emotional and cognitive states which can 
result from malignancy and its treatment. We 
will also review some techniques for helping the 
patient. It is important to remember that the psy­
chological responses to any illness are individ­
ual and largely determined by the patient's past 
experience, psychological strengths, weak­
nesses and social supports, and by the pa­
tient's values, including religious beliefs. 
Psychological Aspects 
ALTERED SELF-IMAGE 
Most healthy people live with a comforting 
sense of invulnerability; this feeling is violently 
interrupted by the diagnosis of cancer. Patients 
feel numb, shocked, and many even disbelieve 
the accuracy of the diagnosis In extreme situa­
tions this denial can be so strong that the pa­
tient even refuses complete evaluation and 
treatment. 
Usually, as the shock fades and the 
awareness of illness increases, the patient must 
alter his or her self-image to include the un­
pleasant concepts of being sick and of being a 
Correspondence and reprtnt requests to Or. Joel J 
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patient; this frequently results in a loss of se[f­
esteem as illness is often equated with inferi·, 
ority, dependency, and helplessness 
In addition to feelings of helplessness the 
cancer patient may even wonder if he or she is 
responsible for causing the illness. "If I had 
given up smoking 1 0 years ago, maybe this 
wouldn't be happening to met" Further, the be­
lief that God punishes sinners with illness may 
motivate the patient to wonder if the cancer is a 
punishment for past sins, known or unknown. II 
is common to hear patients angrily protest. 
"What have I done to deserve this?" These an· 
gry and guilty feelings often contribute to de­
pression and hopelessness. 
Job performance is another very impor· 
tant aspect of self-image for most people The 
cancer may be so debilitating that many weeks 
are lost from the Job or homemaking, and these 
functions may have to be severely curtailed of 
discontinued. This frequently leads to a feeling 
of uselessness and a marked loss of self-es­
teem. 
ALTERED BODY IMAGE 
Just as people have images of themselves 
as personalities, they also have important men· 
tal pictures of their bodies synthesized from pro 
prioceptive experience, self-observation, con· 
cepts of one's personal appearance, the inpul 
of others, and from social norms. Any illness. 
especially one that mutilates the body, can alteJ 
the body-image, and to a greater degree if the 
damage is external. Thus, mastectomy seef1lS, 
to alter body-image more than hysterectornY 
Changes in body-image are associated with 
changes in self-image.' For example, the hys­
terectomy patient may feel that her sexuality is 
diminished, while the patient with a colostomy 
may generate his or her inability to control defe­
cation into a feeling of being generally out of 
control. 
Each body part has individual meaning for 
each person; it is therefore important for the 
physician to explore the meaning of the dam­
aged body part for each patient. Mental agility 
may be highly prized by one person and valued 
· to a much lower degree by someone who is 
' very concerned with physical attractiveness. 
'·RELATIONSHIPS 
Cancer patients often have significant 
problems with relationships. Friends and rela­
tives may withdraw from the patient because 
they are unsure how to handle the subject of the 
patient's illness. The patients themselves may 
withdraw from relationships because they feel 
weak, worthless, depressed, and finished. Post­
operative head and neck cancer patients often 
report that people stare at them and then move 
away. The mastectomy patient may have diffi­
culty finding a comfortable sexual partner. 
Since appearance and health are important fac­
tors determining acceptability in our culture, pa­
tients who feel ugly and sick may fear that oth­
ers will withdraw acceptance and love. 
EMOTIONAL AND COGNITIVE ST A TES 
In addition to problems with self- and 
body-image and relationships, certain abnormal 
mental changes often accompany serious ma­
lignancy. One study of hospitalized cancer pa­
tients revealed that more than one half showed 
Toderate to high levels of depression, and 30% 
had elevated anxiety scores. Almost one quar­
ter of these patients had overall emotional 
symptom patterns virtually similar to those of 
Patients admitted to an emergency psychiatric 
service.2 
·. Depression vs Mourning. Although patho­logical depression is a common finding associ­
ated with cancer, it is often difficult to differenti­
ate it from both the normal process of mourning 
and from the direct physical effects of the malig­
nancy. Many of the signs and symptoms of de­
pression are also characteristic of mourning and 
Physical illness. Insomnia anorexia loss of 
weight, loss of interest in, 
0
usual acti;ities and 
sexuality are hallmarks of pathological depres­
sion but may also result directly from a painful 
malignancy. Diurnal variation in mood is a use­
ful differentiating characteristic, as people with 
physical illness usually feel better when they are 
rested in the morning and worse as the day 
goes on. The reverse is true of clinical depres­
sion. Further, depressed patients often have a 
personal and family history of serious depres­
sion. Self-depreciation and guilt are more char­
acteristic of clinical depression than normal 
mourning. 
Anxiety. Anxiety in the cancer patient can 
result from realistic fears of pain, surgery, muti­
lation, or the side effects of chemotherapy. It 
can also be secondary to fears of helplessness, 
dependency or death and can add further debi­
lity to the patient's already troubled course 
since insomnia, nausea, and irritability are fre­
quent accompaniments. 
Organic Problems. Dementia is "a deteri­
oration of previously acquired intellectual abili­
ties of sufficient severity to interfere with job 
functioning, memory, abstract thinking, judg­
ment, personality, and impulse control. " 3 Many 
cancer patients suffer from this loss of in­
tellectual capacity and others even become agi­
tated and out of touch with reality as a function 
of overwhelming stress, sensory isolation, or or­
ganic factors. Pain, fever, electrolyte and endo­
crine changes as well as treatments and medi­
c a Ii on can cause delirium, anxiety, and 
depression. Sedatives, psychotropic medica­
tion, and steroids can produce mental changes. 
Those patients who are quietly disoriented may 
be ignored and therefore undiagnosed. Their 
loosened contact with reality may be very fright­
ening to them and it certainly decreases their 
ability to cope daily or to comply with treatment. 
Defense Mechanisms. All people have un­
conscious mental mechanisms which are used 
to protect the ego from excessive emotional 
stress. Denial is one of the defense mecha­
nisms frequently used by cancer patients. In de­
nial unpleasant information is forgotten, a proc­
ess which can be helpful or detrimental. The 
patient who continues chemotherapy but denies 
his or her unfavorable prognosis may be using 
this defense mechanism constructively to avoid 
anxiety. On the other hand, the patient whose 
denial prevents her from seeking prompt evalu­
ation of a breast mass is hurting herself. 
Polivy et al conducted a pertinent experi-
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ment exploring defense mechanisms in a large 
group of women with breast masses.' The study 
began in the pre-diagnosis phase and the study 
sample was later divided into one group who 
had benign lesions at biopsy and another group 
who had mastectomy for malignancy. The body 
image, self-image, and general mental well­
being of all patients were studied before and 
after surgery and on 6 to 1 2 month follow-up 
Before biopsy both groups strengthened them­
selves and mobilized their resources to deal 
with the stress. They maintained adequate 
body- and self-images and did not show signifi­
cant anxiety or depression. Immediately post­
biopsy the nonmalignant group, feeling safe, 
was able to express their emotions of feeling 
scared, assaulted, and helpless. The mastec­
tomy patients did not express these feelings. 
They were busy maintaining their defenses by 
using denial to deal with the operative stress. 
They were being strong and brave and telling 
their doctors and their husbands and them­
selves that things were going well. Six to 1 2 
months after surgery the nonmalignant group 
was back to normal and the cancer group, hav­
ing survived the acute postoperative phase, was 
now showing evidence of marked decrease in 
self- and body-image with significant evidence 
of depression and anxiety This study is clini­
cally useful because it alerts us to be aware that 
the patient may be hiding emotional symptoms 
in the early postoperative phase when we are 
forming our opinion about her health and prog­
nosis. Up to a year following mastectomy, many 
patients will have significant depression with in­
somnia, anorexia, suicidal ideas, and this is true 
even if the patients have an excellent long-term 
prognosis. About 1 5% will seek professional 
help for mastectomy-related problems and 
many who had normal and satisfying pre-mas­
tectomy sexual relations will have significant 
sexual difficulties for many months post-sur­
gery." 
Therapeutic Management 
A "temperogluteal" approach is usually 
required to competently evaluate the patient, to 
understand his or her feelings, and to facilitate 
the resolution of the problems. This approach 
means sitting down and spending time with the 
patient. A serious discussion of feelings is 
highly unlikely if you are standing by the bed­
side writing in the chart or if you are in your of-
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lice answering the phone or being interrupted 
by your nurse. The presence of a box of klee­
nex is an important nonverbal message to the 
patient that you are a doctor who can handle 
the expression of feeling. Even in privacy and 
with an interested doctor, the patient may give 
an inaccurate social response, · 'I'm fine.·· 
when greeted. If you sit down and say, "How 
are you really doing?·', there is a good chance 
the patient will talk honestly with you Once the 
patient knows you are really interested in his or 
her feelings, then it is appropriate to find out ex­
actly what the person is feeling about the condi­
tion, about the diseased body part and about 
the future. It is also important to find out what 
the patient knows about cancer as beliefs about 
treatment and prognosis may be inaccurate. In 
order to understand each patient's emotional 
response to the cancer and the person ·s 
strengths and weaknesses, the physician 
should ask personal questions to explore the 
patient's character, to determine how stress has 
been handled in the past, and what the per­
sonal meaning of the damaged organ or illness 
is to the individual. It is equally important to re­
spect a patient's need for privacy and not to in­
sist on exploration of these issues if the patient 
is unwilling or unready. 
Understanding the patient's personality 
type can be extremely important in helping you 
to individualize your approach A very depen­
dent patient will usually be comforted by a fairly 
parental approach: ·'I'm going to help you gel 
through this; things are under control." If you 
are dealing with a person who is more obses· 
sive-compulsive, for example, someone who is 
hard driving, meticulous, and likes to control his 
or her anxiety by having facts and information, 
an approach that offers facts and a sharing ol 
control with the patient will be welcomed 
whereas the parental approach may make this 
patient very anxious. There are many other per­
sonality types and guidelines for medical man­
agement." 
In the advanced stages of malignancy 
many patients fear abandonment, a fear often 
greater than the fear of death. Repeated medi­
cally unnecessary calls for attention and 
requests for pain medication can be the pa­
tients' communication of their fear of loneliness 
and their attempt to obtain reassurance tha'. 
they will be attended. 
We may forget to evaluate how various 
lamily members are feeling about the illness 
and lhe future. Their attitudes and support can 
be.;critical. They may need help in coping with 
the illness and in dealing with their feelings 
about it. Mobilization of self-help organizations 
can also be effective by demonstrating that oth­
ers with similar histories have returned to rela­
tively normal and effective lives. 
A stance of realistic hopefulness is most 
important in helping the patient. This concept 
embodies two necessary components of empa­
thetic medical care; to be honest while retaining 
hope. No matter how grim the situation, no mat­
ter how grave the prognosis, a thoughtful physi­
cian can always offer something realistically 
hopeful. The ability to say, "we are going to 
stick with you, you are not going to be alone, 
we are going to keep your pain under control," 
is extremely helpful and comforting to the pa­
lient. 
Most of the psychological problems of the 
cancer patient can be effectively managed by 
the primary care physician. Supportive psycho­
therapy is often sufficient; however, psychiatric 
evaluation, psychopharmacology, behavior 
therapy, or even electroconvulsive therapy may 
be indicated. Consultation with a psychiatrist 
skilled in the emotional problems of the medi­
cally ill is indicated if the emotional diagnosis is 
unclear, if there are questions about treatments, 
or if the primary physician is having difficulty 
managing the symptoms. It is important to prop­
erly prepare the patient for psychiatric consulta-
lion by emphas1z1ng that many people have dif­
ficulty coping with illness and that the 
psychiatrist will offer the patient and physician 
advice about the emotional aspects of the ill­
ness and about the effects of treatments and 
medicines on mental functioning. Naturally, psy­
chiatric consultation is best accepted when the 
psychiatrist is a regular member of a multi­
disciplinary team routinely working with cancer 
patients and their families. 
REFERENCES 
1. SECORD PF, JOUAAAD SM: The appraisal of body-ca­
thexis: Body-Cathexis and the self. J Consult Psycho/ 
17 343-347, 1953. 
2. CRAIG T J, ABELOFF: Psychiatric symptomatology among 
hospitalized cancer patients. Am J Psychiat 1 31 : 1 323-
1327, 1974. 
3. Diagnos1ic and S1atistical Manual of Men1al Disorders, 
3rd Draft. American Psychiatric Association, Washing­
ton, DC, 1978. 
4. Pouvv J: Psychological effects of mastectomy on a 
woman's feminine self-concept. Journal of Nervous and 
Mental Disease, 164:77-87, 1977. 
5. JAMISON KR, WELUSCH DK, PASNAU RO: Psychosocial 
Aspects of mastectomy: I. The woman's perspective. 
American Journal of Psychiatry, 135:432-436, 1978. 
6. KAHANA RJ, ZEBAING GL: Personality types in medical 
management, in NE Zinberg, (ed), Psychiatry and Medi­
cal Practice in a General Hospital. New York, Inter­
national University Press, 1 964. 
SILVERMAN PSYCHOLOGICAL ASPECTS OF CANCER / 55 
MEDICAL COLLEGE OF VIRGINIA 
17th Annual RADIOLOGY POSTGRADUATE COURSE­
CHEST RADIOLOGY 
March 1-5, 1981 
Williamsburg Conference Center, Williamsburg, Virginia 
MONDAY, MARCH 2 
MODERATOR: Michael C. Beachley, MD. 
CONVENTIONAL CHEST TOMOGRAPHY: James C. Reed, M.O. 
THE LATERAL CHEST---SELECTED TOPICS----l: Anthony V. Proto, M.D. 
THE LATERAL CHEST---SELECTED TOPICS----ll: Anthony V. Proto, MD. 
COMPUTED TOMOGRAPHY OF THE LUNG: Stuart S. Sagel, MD. 
IMMUNOLOGICAL DISEASES AS EXPRESSED IN THE LUNGS: Elias G. Theros, MD. 
MODERATOR: Daniel A. Henry, M.D. 
COMPUTED TOMOGRAPHY OF THE PLEURA ANO CHEST WALL: Stuart S. Sagel, MD. 
PULMONARY COLLAPSE--1: Anthony V. Proto, M.D. 
PULMONARY COLLAPSE--11: Anthony V. Proto, MD. 
COLLAGEN VASCULAR DISEASES OF THE LUNGS Elias G. Theros, MD. 
TUESOA Y, MARCH 3 
MODERATOR: Tapan A. Hazra, MD. 
CT IN EVALUATION OF VASCULAR ANO NON-VASCULAR MEDIASTINAL LESIONS: Stuart 
S. Sagel, MD. 
THE EVALUATION OF PERIPHERAL MASSES IN THE LUNGS: Elias G. Theros, M.D. 
THE VARYING MANIFESTATIONS OF BRONCHOGENIC NEOPLASMS Elias G. Theros, 
M.D. 
NEEDLE ASPIRATION BIOPSY OF THE THORAX: Stuart S. Sagel, MD. 
PREOPERATIVE EVALUATION OF THORACIC NEOPLASM: Szabolcs Szentpetery, MD. 
RADIATION THERAPY OF THORACIC MALIGNANCY: Tapan A. Hazra, MD. 
WEDNESOA Y, MARCH 4 
MODERATOR: M. Pinson Neal, Jr., MD. 
RADIOLOGY IN THE INTENSIVE CARE UNIT: Theresa C. McLoud, MD. 
SARCOID: Daniel A. Henry, MD. 
PULMONARY INFECTIONS IN THE COMPROMISED HOST: James C. Reed, M.O. 
AIRWAY DISEASES IN CHILDREN: Michael 8. Kodroff, M.D. 
THE RADIOLOGY OF CHRONIC INFECTIOUS PULMONARY DISEASE: James C. Reed, 
M.D. 
OCCUPATIONAL LUNG DISEASE Theresa C. McLoud, M.D. 
,MODERATOR: Michael B. Kodroff, M.D. 
THORACIC LYMPHOMA: James W. Walsh, M.D. 
RESPIRATORY DISTRESS SYNDROME-MEDICAL/SURGICAL CAUSES: Michael 8. 
Kodroff, M.D. 
RESPIRATORY DISTRESS SYNDROME---CARQIAC CAUSES Michael 8. Kodroff, M.D. 
PNEUMOTHORAX CLINICAL, PHYSIOLOGIC, RADIOGRAPHIC ASPECTS: Theresa C. 
McLoud, M .D. 
ULTRASOUND OF THE CHEST: William H. Brewer, M.D. 
THURSOA Y, MARCH 5 
·MODERATOR: Frederick S. Vines, M.D. 
VIRAL, MYCOPLASMA, AND LEGIONNAIRES PNEUMONIAS James C. Reed, M.D. 
NUCLEAR MEDICINE UPDATE: James L. Tatum, M.D. 
RADIOLOGY OF EMBOLIC DISEASE: Frederick S. Vines, M.D. 
CHEST TRAUMA: Daniel A. Henry, M.D. 
INTERSTITIAL LUNG DISEASES: Theresa C. McLoud, M.D. 
THORACIC ANGIOGRAPHY: Michael C. Beachley, M.D. 
For further information contact MCV Department of CME, Telephone 804/786-0494; Box 48, 
Medical College of Virginia, Richmond, Virginia 23298. 
Tms year the men and women ___ . of A.H. Robins Sergea�t\ 
a� t,lt' will be helping REA & TICK COUAR 
EO.AeCETS 
�  meet the needs of �::·:�:.: �:i'.�n:i:��r,\ more people . m more ways in more parts 11 · of the world than ever before. 
_ _:-.: '"R'":t Ana tI:us growi_ng �v?lvement i 
If a healthier, happier life 1s 
.. ...... •1@m-Ji@-j.j the most satisfying I� ,m 
DM. • · • 111 . .1. 
}ff. way we can 1magme , �-
.. �f· ·.: · . . . to demonstrate the � g�� world of opportunity 1 �=�-still facing us here in Richmond. 
A·H·ROBINS 
CONTENTS (continued from back cover) 
Volume Sixteen • Numbers One and Two 
The 51st Annual McGuire Lecture Series 
Outpatient Obstetrics and Gynecology--Part II 
Presented by the Departments of Obstetrics and 
Gynecology and Continuing Medical Education 
W. GLENN HURT, M.D., Guest Editor 
Endometriosis 
W GLENN HURT, MD 
RAY A. WERTHEIM, MD 
Urinary Incontinence in Women 
J. ANDREW FANTL, MD 
Cervical Cytology and Colposcopy 
W. GLENN HURT, MD 
Office Endometrial Sampling 
STEPHEN A. COHEN, MD 
W GLENN HURT, MD 
Evaluation and Management of Adnexal Masses 
DEAN R. GOPLERUD, MO 
Some Psychological Aspects of Dealing with Cancer 
JOEL J. SILVERMAN, MO 
32 
36 
43 
46 
49 
52 
MCV/13 
MEDICAL COLLEGE OF VIRGINIA QUARTERLY 
PO BOX 26 • MCV STATION 
RICHMOND, VIRGINIA 23298 
CONTENTS 
Volume Sixteen • Numbers One and Two 
The 51st Annual McGuire Lecture Series 
Outpatient Obstetrics and Gynecology-Part I 
Presented by the Departments of Obstetrics and 
Gynecology and Continuing Medical Education 
W. GLENN HURT, MD, Guest Editor 
Antenatal Genetic Studies 
FAY REDWINE, MS, MD 
Identification of the High-Risk Gravida 4 
ROBERT E. PETRES, MD 
EMILY M. COOGAN, RN, MS, OGNP 
Management of the High-Risk Gravida 9 
SHELBY JARRELL, MD 
Relaxation of the Supporting Structures of the Female 
Pelvis 14 
DAVID H. NICHOLS, MD 
Menstrual Abnormalities 24 
LEO J. DUNN, MD 
Contraception Versus Sterilization 27 
THAMPU KUMARASAMY, MD, FRCS, FRCOG, MRCP 
(continued on inside back cover) 
Nonprofit Org. 
U.S. Postage Paid! 
Permit No. 930 
Richmond, Va. 
